JPH03261755A - Benzocycloalkane derivative and production and drug thereof - Google Patents
Benzocycloalkane derivative and production and drug thereofInfo
- Publication number
- JPH03261755A JPH03261755A JP13633190A JP13633190A JPH03261755A JP H03261755 A JPH03261755 A JP H03261755A JP 13633190 A JP13633190 A JP 13633190A JP 13633190 A JP13633190 A JP 13633190A JP H03261755 A JPH03261755 A JP H03261755A
- Authority
- JP
- Japan
- Prior art keywords
- value
- formula
- urea
- elemental analysis
- difluorophenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 8
- 239000003814 drug Substances 0.000 title abstract description 3
- 229940079593 drug Drugs 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 claims abstract description 42
- 150000003839 salts Chemical class 0.000 claims abstract description 22
- 125000001424 substituent group Chemical group 0.000 claims abstract description 20
- 125000003118 aryl group Chemical group 0.000 claims abstract description 12
- 102000001494 Sterol O-Acyltransferase Human genes 0.000 claims abstract description 6
- 108010054082 Sterol O-acyltransferase Proteins 0.000 claims abstract description 6
- 229940123324 Acyltransferase inhibitor Drugs 0.000 claims abstract 3
- 239000002404 acyltransferase inhibitor Substances 0.000 claims abstract 3
- 125000001183 hydrocarbyl group Chemical group 0.000 claims abstract 3
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims 8
- 125000004429 atom Chemical group 0.000 claims 1
- 125000004354 sulfur functional group Chemical group 0.000 claims 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 abstract description 57
- 239000004202 carbamide Substances 0.000 abstract description 29
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 abstract description 18
- 201000001320 Atherosclerosis Diseases 0.000 abstract description 4
- 201000010099 disease Diseases 0.000 abstract description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 4
- 229910052717 sulfur Inorganic materials 0.000 abstract description 4
- 208000035150 Hypercholesterolemia Diseases 0.000 abstract description 3
- 230000007059 acute toxicity Effects 0.000 abstract description 2
- 231100000403 acute toxicity Toxicity 0.000 abstract description 2
- 229910052760 oxygen Inorganic materials 0.000 abstract description 2
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 abstract 1
- 239000012442 inert solvent Substances 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 141
- 238000000921 elemental analysis Methods 0.000 description 72
- -1 5ee-butyl Chemical group 0.000 description 53
- 239000002904 solvent Substances 0.000 description 29
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 28
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 28
- 229910052757 nitrogen Inorganic materials 0.000 description 28
- 238000005259 measurement Methods 0.000 description 26
- 239000013078 crystal Substances 0.000 description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 22
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 20
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 18
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 18
- 229910052731 fluorine Inorganic materials 0.000 description 18
- 238000000034 method Methods 0.000 description 18
- 239000000203 mixture Substances 0.000 description 17
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 16
- 238000006243 chemical reaction Methods 0.000 description 16
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 15
- 238000001953 recrystallisation Methods 0.000 description 15
- PQNFLJBBNBOBRQ-UHFFFAOYSA-N indane Chemical compound C1=CC=C2CCCC2=C1 PQNFLJBBNBOBRQ-UHFFFAOYSA-N 0.000 description 14
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 11
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 10
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 235000012000 cholesterol Nutrition 0.000 description 9
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 9
- 230000002401 inhibitory effect Effects 0.000 description 9
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 150000002430 hydrocarbons Chemical group 0.000 description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 125000000217 alkyl group Chemical group 0.000 description 7
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- 125000003545 alkoxy group Chemical group 0.000 description 6
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 6
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 6
- 125000004432 carbon atom Chemical group C* 0.000 description 6
- 239000003054 catalyst Substances 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 5
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 5
- 235000011054 acetic acid Nutrition 0.000 description 5
- 235000015278 beef Nutrition 0.000 description 5
- 239000003638 chemical reducing agent Substances 0.000 description 5
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 5
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 5
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 5
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 230000035484 reaction time Effects 0.000 description 5
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 5
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 241000700159 Rattus Species 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 4
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 4
- 208000026106 cerebrovascular disease Diseases 0.000 description 4
- 150000001840 cholesterol esters Chemical class 0.000 description 4
- 125000000623 heterocyclic group Chemical group 0.000 description 4
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 4
- 229910052739 hydrogen Inorganic materials 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 description 4
- 235000011181 potassium carbonates Nutrition 0.000 description 4
- 238000006722 reduction reaction Methods 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 238000009825 accumulation Methods 0.000 description 3
- 125000004414 alkyl thio group Chemical group 0.000 description 3
- 125000006615 aromatic heterocyclic group Chemical group 0.000 description 3
- 125000003710 aryl alkyl group Chemical group 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000004440 column chromatography Methods 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- PSLIMVZEAPALCD-UHFFFAOYSA-N ethanol;ethoxyethane Chemical compound CCO.CCOCC PSLIMVZEAPALCD-UHFFFAOYSA-N 0.000 description 3
- 150000002170 ethers Chemical class 0.000 description 3
- 229910052736 halogen Inorganic materials 0.000 description 3
- 150000002367 halogens Chemical class 0.000 description 3
- 239000012280 lithium aluminium hydride Substances 0.000 description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 239000012279 sodium borohydride Substances 0.000 description 3
- 229910000033 sodium borohydride Inorganic materials 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 239000008096 xylene Substances 0.000 description 3
- OPXWZSISANXPRU-UHFFFAOYSA-N 2,6-ditert-butyl-4-[(2,3-dihydro-1h-inden-2-ylamino)methyl]phenol;hydrochloride Chemical compound Cl.CC(C)(C)C1=C(O)C(C(C)(C)C)=CC(CNC2CC3=CC=CC=C3C2)=C1 OPXWZSISANXPRU-UHFFFAOYSA-N 0.000 description 2
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 2
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 2
- JGSDUJVEVSLOKC-UHFFFAOYSA-N 4,6-dimethyl-2,3-dihydro-1h-inden-2-amine;hydrochloride Chemical compound Cl.CC1=CC(C)=CC2=C1CC(N)C2 JGSDUJVEVSLOKC-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 2
- 239000003377 acid catalyst Substances 0.000 description 2
- 238000005917 acylation reaction Methods 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000010531 catalytic reduction reaction Methods 0.000 description 2
- 206010008118 cerebral infarction Diseases 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- GCFHZZWXZLABBL-UHFFFAOYSA-N ethanol;hexane Chemical compound CCO.CCCCCC GCFHZZWXZLABBL-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 150000008282 halocarbons Chemical class 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 239000012948 isocyanate Substances 0.000 description 2
- 150000002513 isocyanates Chemical class 0.000 description 2
- 150000002576 ketones Chemical class 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 229940098779 methanesulfonic acid Drugs 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 208000031225 myocardial ischemia Diseases 0.000 description 2
- WFQDKMNKFISIBD-UHFFFAOYSA-N n-[(2-chlorophenyl)methyl]-2,3-dihydro-1h-inden-2-amine;hydrochloride Chemical compound Cl.ClC1=CC=CC=C1CNC1CC2=CC=CC=C2C1 WFQDKMNKFISIBD-UHFFFAOYSA-N 0.000 description 2
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 230000000069 prophylactic effect Effects 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 238000005932 reductive alkylation reaction Methods 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 235000017550 sodium carbonate Nutrition 0.000 description 2
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 2
- 125000004434 sulfur atom Chemical group 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 150000003672 ureas Chemical class 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- KDDNKZCVYQDGKE-UHFFFAOYSA-N (2-chlorophenyl)methanamine Chemical compound NCC1=CC=CC=C1Cl KDDNKZCVYQDGKE-UHFFFAOYSA-N 0.000 description 1
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 1
- MIOPJNTWMNEORI-GMSGAONNSA-N (S)-camphorsulfonic acid Chemical compound C1C[C@@]2(CS(O)(=O)=O)C(=O)C[C@@H]1C2(C)C MIOPJNTWMNEORI-GMSGAONNSA-N 0.000 description 1
- HZDWPNSKIXWMSE-UHFFFAOYSA-N 1-[(2-chlorophenyl)methyl]-3-(2,4-difluorophenyl)-1-(2,3-dihydro-1h-inden-2-yl)urea Chemical compound FC1=CC(F)=CC=C1NC(=O)N(C1CC2=CC=CC=C2C1)CC1=CC=CC=C1Cl HZDWPNSKIXWMSE-UHFFFAOYSA-N 0.000 description 1
- XNJLTBXDFQRULS-UHFFFAOYSA-N 1-[(3,5-ditert-butyl-4-hydroxyphenyl)methyl]-3-(2,4-difluorophenyl)-1-(2,3-dihydro-1h-inden-2-yl)urea Chemical compound CC(C)(C)C1=C(O)C(C(C)(C)C)=CC(CN(C2CC3=CC=CC=C3C2)C(=O)NC=2C(=CC(F)=CC=2)F)=C1 XNJLTBXDFQRULS-UHFFFAOYSA-N 0.000 description 1
- VWLSPHJBOJINPS-UHFFFAOYSA-N 1-[(4-chlorophenyl)methyl]-3-(2,4-difluorophenyl)-1-(2,3-dihydro-1h-inden-2-yl)urea Chemical compound FC1=CC(F)=CC=C1NC(=O)N(C1CC2=CC=CC=C2C1)CC1=CC=C(Cl)C=C1 VWLSPHJBOJINPS-UHFFFAOYSA-N 0.000 description 1
- SWJNTBBNQYZJGT-UHFFFAOYSA-N 1-[(5-tert-butyl-4-hydroxy-2-methylphenyl)methyl]-3-(2,4-difluorophenyl)-1-(2,3-dihydro-1h-inden-2-yl)urea Chemical compound CC1=CC(O)=C(C(C)(C)C)C=C1CN(C(=O)NC=1C(=CC(F)=CC=1)F)C1CC2=CC=CC=C2C1 SWJNTBBNQYZJGT-UHFFFAOYSA-N 0.000 description 1
- NFNVHZVLKBTEJE-UHFFFAOYSA-N 1-benzyl-1-(7-chloro-3,4-dihydro-2h-chromen-4-yl)-3-(2,4-difluorophenyl)urea Chemical compound FC1=CC(F)=CC=C1NC(=O)N(C1C2=CC=C(Cl)C=C2OCC1)CC1=CC=CC=C1 NFNVHZVLKBTEJE-UHFFFAOYSA-N 0.000 description 1
- AONKLPCWRICHGQ-UHFFFAOYSA-N 1-benzyl-3-(2,4-difluorophenyl)-1-(1,2,3,4-tetrahydronaphthalen-2-yl)urea Chemical compound FC1=CC(F)=CC=C1NC(=O)N(C1CC2=CC=CC=C2CC1)CC1=CC=CC=C1 AONKLPCWRICHGQ-UHFFFAOYSA-N 0.000 description 1
- RXPIHGAPTAAVMY-UHFFFAOYSA-N 1-benzyl-3-(2,4-difluorophenyl)-1-(2,3-dihydro-1H-inden-2-yl)urea Chemical compound C(C1=CC=CC=C1)N(C(=O)NC1=C(C=C(C=C1)F)F)C1CC2=CC=CC=C2C1 RXPIHGAPTAAVMY-UHFFFAOYSA-N 0.000 description 1
- QCSARUYDCYVGIZ-UHFFFAOYSA-N 1-benzyl-3-(2,4-difluorophenyl)-1-(4,5,6-trimethoxy-2,3-dihydro-1h-inden-2-yl)urea Chemical compound C1C=2C(OC)=C(OC)C(OC)=CC=2CC1N(C(=O)NC=1C(=CC(F)=CC=1)F)CC1=CC=CC=C1 QCSARUYDCYVGIZ-UHFFFAOYSA-N 0.000 description 1
- KBGGSUVMLTYOIT-UHFFFAOYSA-N 1-benzyl-3-(2,4-difluorophenyl)-1-(4,6-dimethyl-2,3-dihydro-1h-inden-2-yl)urea Chemical compound C1C=2C(C)=CC(C)=CC=2CC1N(C(=O)NC=1C(=CC(F)=CC=1)F)CC1=CC=CC=C1 KBGGSUVMLTYOIT-UHFFFAOYSA-N 0.000 description 1
- 125000004343 1-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C([H])([H])[H] 0.000 description 1
- XLBXXCLTWMOULT-UHFFFAOYSA-N 2,6-dimethoxy-4-[(6,7,8,9-tetrahydro-5h-benzo[7]annulen-5-ylamino)methyl]phenol;4-methylbenzenesulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1.COC1=C(O)C(OC)=CC(CNC2C3=CC=CC=C3CCCC2)=C1 XLBXXCLTWMOULT-UHFFFAOYSA-N 0.000 description 1
- UVRBDAHNGNQJAD-UHFFFAOYSA-N 2,6-dimethoxy-4-[(6,7,8,9-tetrahydro-5h-benzo[7]annulen-6-ylamino)methyl]phenol Chemical compound COC1=C(O)C(OC)=CC(CNC2CC3=CC=CC=C3CCC2)=C1 UVRBDAHNGNQJAD-UHFFFAOYSA-N 0.000 description 1
- WAAHWZMTHWIFGT-UHFFFAOYSA-N 2,6-ditert-butyl-4-[(2,3-dihydro-1h-inden-2-ylamino)methyl]phenol Chemical compound CC(C)(C)C1=C(O)C(C(C)(C)C)=CC(CNC2CC3=CC=CC=C3C2)=C1 WAAHWZMTHWIFGT-UHFFFAOYSA-N 0.000 description 1
- HPTYBXWMQQXMDO-UHFFFAOYSA-N 2-[(2,3-dihydro-1h-inden-2-ylamino)methyl]-5-methoxyphenol Chemical compound OC1=CC(OC)=CC=C1CNC1CC2=CC=CC=C2C1 HPTYBXWMQQXMDO-UHFFFAOYSA-N 0.000 description 1
- LMHHFZAXSANGGM-UHFFFAOYSA-N 2-aminoindane Chemical compound C1=CC=C2CC(N)CC2=C1 LMHHFZAXSANGGM-UHFFFAOYSA-N 0.000 description 1
- 125000005999 2-bromoethyl group Chemical group 0.000 description 1
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- OGNYBGPKUOFYPE-UHFFFAOYSA-N 2-hydroxyimino-4,6-dimethyl-3h-inden-1-one Chemical compound CC1=CC(C)=CC2=C1CC(=NO)C2=O OGNYBGPKUOFYPE-UHFFFAOYSA-N 0.000 description 1
- DDTKYVBFPULMGN-UHFFFAOYSA-N 2-methyl-6-propan-2-ylaniline Chemical compound CC(C)C1=CC=CC(C)=C1N DDTKYVBFPULMGN-UHFFFAOYSA-N 0.000 description 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- PHFKBBYVSFSQBR-UHFFFAOYSA-N 3-(2,4-difluorophenyl)-1-(2,3-dihydro-1h-inden-2-yl)-1-(1-phenylethyl)urea Chemical compound C=1C=CC=CC=1C(C)N(C1CC2=CC=CC=C2C1)C(=O)NC1=CC=C(F)C=C1F PHFKBBYVSFSQBR-UHFFFAOYSA-N 0.000 description 1
- QQLHSDOTDLJBFM-UHFFFAOYSA-N 3-(2,4-difluorophenyl)-1-(2,3-dihydro-1h-inden-2-yl)-1-(2-phenylethyl)urea Chemical compound FC1=CC(F)=CC=C1NC(=O)N(C1CC2=CC=CC=C2C1)CCC1=CC=CC=C1 QQLHSDOTDLJBFM-UHFFFAOYSA-N 0.000 description 1
- JXAPZRHONOJPPE-UHFFFAOYSA-N 3-(2,4-difluorophenyl)-1-(2,3-dihydro-1h-inden-2-yl)-1-(pyridin-2-ylmethyl)urea Chemical compound FC1=CC(F)=CC=C1NC(=O)N(C1CC2=CC=CC=C2C1)CC1=CC=CC=N1 JXAPZRHONOJPPE-UHFFFAOYSA-N 0.000 description 1
- DFTQFCVSJBXHLU-UHFFFAOYSA-N 3-(2,4-difluorophenyl)-1-(2,3-dihydro-1h-inden-2-yl)-1-(pyridin-3-ylmethyl)urea Chemical compound FC1=CC(F)=CC=C1NC(=O)N(C1CC2=CC=CC=C2C1)CC1=CC=CN=C1 DFTQFCVSJBXHLU-UHFFFAOYSA-N 0.000 description 1
- DAAQYTRQXPKNBR-UHFFFAOYSA-N 3-(2,4-difluorophenyl)-1-(2,3-dihydro-1h-inden-2-yl)-1-(thiophen-2-ylmethyl)urea Chemical compound FC1=CC(F)=CC=C1NC(=O)N(C1CC2=CC=CC=C2C1)CC1=CC=CS1 DAAQYTRQXPKNBR-UHFFFAOYSA-N 0.000 description 1
- HKOPPEIOIAJTQJ-UHFFFAOYSA-N 3-(2,4-difluorophenyl)-1-(2,3-dihydro-1h-inden-2-yl)-1-[(2,4-dimethylphenyl)methyl]urea Chemical compound CC1=CC(C)=CC=C1CN(C(=O)NC=1C(=CC(F)=CC=1)F)C1CC2=CC=CC=C2C1 HKOPPEIOIAJTQJ-UHFFFAOYSA-N 0.000 description 1
- WNEXMPRZMRFQBM-UHFFFAOYSA-N 3-(2,4-difluorophenyl)-1-(2,3-dihydro-1h-inden-2-yl)-1-[(2,5-dimethylphenyl)methyl]urea Chemical compound CC1=CC=C(C)C(CN(C2CC3=CC=CC=C3C2)C(=O)NC=2C(=CC(F)=CC=2)F)=C1 WNEXMPRZMRFQBM-UHFFFAOYSA-N 0.000 description 1
- CWCWHXGFBDGDFL-UHFFFAOYSA-N 3-(2,4-difluorophenyl)-1-(2,3-dihydro-1h-inden-2-yl)-1-[(2-hydroxy-4-methoxyphenyl)methyl]urea Chemical compound OC1=CC(OC)=CC=C1CN(C(=O)NC=1C(=CC(F)=CC=1)F)C1CC2=CC=CC=C2C1 CWCWHXGFBDGDFL-UHFFFAOYSA-N 0.000 description 1
- GXRBURAXWFAEBX-UHFFFAOYSA-N 3-(2,4-difluorophenyl)-1-(2,3-dihydro-1h-inden-2-yl)-1-[(2-methoxyphenyl)methyl]urea Chemical compound COC1=CC=CC=C1CN(C(=O)NC=1C(=CC(F)=CC=1)F)C1CC2=CC=CC=C2C1 GXRBURAXWFAEBX-UHFFFAOYSA-N 0.000 description 1
- LKTBPWKRVPBTHL-UHFFFAOYSA-N 3-(2,4-difluorophenyl)-1-(2,3-dihydro-1h-inden-2-yl)-1-[(3,4-dimethoxyphenyl)methyl]urea Chemical compound C1=C(OC)C(OC)=CC=C1CN(C(=O)NC=1C(=CC(F)=CC=1)F)C1CC2=CC=CC=C2C1 LKTBPWKRVPBTHL-UHFFFAOYSA-N 0.000 description 1
- DISLFLSYJVUSDC-UHFFFAOYSA-N 3-(2,4-difluorophenyl)-1-(2,3-dihydro-1h-inden-2-yl)-1-[(4-hydroxy-2,5-dimethylphenyl)methyl]urea Chemical compound C1=C(O)C(C)=CC(CN(C2CC3=CC=CC=C3C2)C(=O)NC=2C(=CC(F)=CC=2)F)=C1C DISLFLSYJVUSDC-UHFFFAOYSA-N 0.000 description 1
- XVEDFODWRWDZCP-UHFFFAOYSA-N 3-(2,4-difluorophenyl)-1-(2,3-dihydro-1h-inden-2-yl)-1-[(4-hydroxy-2-methyl-5-propan-2-ylphenyl)methyl]urea Chemical compound C1=C(O)C(C(C)C)=CC(CN(C2CC3=CC=CC=C3C2)C(=O)NC=2C(=CC(F)=CC=2)F)=C1C XVEDFODWRWDZCP-UHFFFAOYSA-N 0.000 description 1
- TWNDCVLJEFDEBM-UHFFFAOYSA-N 3-(2,4-difluorophenyl)-1-(2,3-dihydro-1h-inden-2-yl)-1-[(4-hydroxy-3,5-dimethoxyphenyl)methyl]urea Chemical compound COC1=C(O)C(OC)=CC(CN(C2CC3=CC=CC=C3C2)C(=O)NC=2C(=CC(F)=CC=2)F)=C1 TWNDCVLJEFDEBM-UHFFFAOYSA-N 0.000 description 1
- QWLJXIHFINEAJX-UHFFFAOYSA-N 3-(2,4-difluorophenyl)-1-(2,3-dihydro-1h-inden-2-yl)-1-[(4-hydroxy-3,5-dimethylphenyl)methyl]urea Chemical compound CC1=C(O)C(C)=CC(CN(C2CC3=CC=CC=C3C2)C(=O)NC=2C(=CC(F)=CC=2)F)=C1 QWLJXIHFINEAJX-UHFFFAOYSA-N 0.000 description 1
- WQCNMZYVQCPIAX-UHFFFAOYSA-N 3-(2,4-difluorophenyl)-1-(2,3-dihydro-1h-inden-2-yl)-1-[(4-methoxy-2,5-dimethylphenyl)methyl]urea Chemical compound C1=C(C)C(OC)=CC(C)=C1CN(C(=O)NC=1C(=CC(F)=CC=1)F)C1CC2=CC=CC=C2C1 WQCNMZYVQCPIAX-UHFFFAOYSA-N 0.000 description 1
- LRAKIWUCZHWYIZ-UHFFFAOYSA-N 3-(2,4-difluorophenyl)-1-(2,3-dihydro-1h-inden-2-yl)-1-[(4-methylphenyl)methyl]urea Chemical compound C1=CC(C)=CC=C1CN(C(=O)NC=1C(=CC(F)=CC=1)F)C1CC2=CC=CC=C2C1 LRAKIWUCZHWYIZ-UHFFFAOYSA-N 0.000 description 1
- ZWQSZYKSTJQQOF-UHFFFAOYSA-N 3-(2,4-difluorophenyl)-1-(2,3-dihydro-1h-inden-2-yl)-1-[(4-methylsulfanylphenyl)methyl]urea Chemical compound C1=CC(SC)=CC=C1CN(C(=O)NC=1C(=CC(F)=CC=1)F)C1CC2=CC=CC=C2C1 ZWQSZYKSTJQQOF-UHFFFAOYSA-N 0.000 description 1
- CYKRIKRSOGYMID-UHFFFAOYSA-N 3-(2,4-difluorophenyl)-1-(2,3-dihydro-1h-inden-2-yl)-1-[[4-hydroxy-3,5-di(propan-2-yl)phenyl]methyl]urea Chemical compound CC(C)C1=C(O)C(C(C)C)=CC(CN(C2CC3=CC=CC=C3C2)C(=O)NC=2C(=CC(F)=CC=2)F)=C1 CYKRIKRSOGYMID-UHFFFAOYSA-N 0.000 description 1
- KFNVGXHIEPAFFM-UHFFFAOYSA-N 3-(2,4-difluorophenyl)-1-(2,3-dihydro-1h-inden-2-yl)-1-phenylurea Chemical compound FC1=CC(F)=CC=C1NC(=O)N(C=1C=CC=CC=1)C1CC2=CC=CC=C2C1 KFNVGXHIEPAFFM-UHFFFAOYSA-N 0.000 description 1
- VZZNCUVCXGZGQM-UHFFFAOYSA-N 3-(2,4-difluorophenyl)-1-[(4-hydroxy-3,5-dimethoxyphenyl)methyl]-1-(1,2,3,4-tetrahydronaphthalen-1-yl)urea Chemical compound COC1=C(O)C(OC)=CC(CN(C2C3=CC=CC=C3CCC2)C(=O)NC=2C(=CC(F)=CC=2)F)=C1 VZZNCUVCXGZGQM-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- 125000003682 3-furyl group Chemical group O1C([H])=C([*])C([H])=C1[H] 0.000 description 1
- 125000006201 3-phenylpropyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 1
- 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- VPOLDNGGPCQFNS-UHFFFAOYSA-N 4-[(2,3-dihydro-1h-inden-1-ylamino)methyl]-2,6-dimethoxyphenol;oxalic acid Chemical compound OC(=O)C(O)=O.COC1=C(O)C(OC)=CC(CNC2C3=CC=CC=C3CC2)=C1 VPOLDNGGPCQFNS-UHFFFAOYSA-N 0.000 description 1
- OBWLHDSAEDCQMK-UHFFFAOYSA-N 4-[(2,3-dihydro-1h-inden-2-ylamino)methyl]-2,3,6-trimethylphenol Chemical compound CC1=C(O)C(C)=CC(CNC2CC3=CC=CC=C3C2)=C1C OBWLHDSAEDCQMK-UHFFFAOYSA-N 0.000 description 1
- INGYUALHKPXCGN-UHFFFAOYSA-N 4-[(2,3-dihydro-1h-inden-2-ylamino)methyl]-2,5-dimethylphenol;hydrochloride Chemical compound Cl.C1=C(O)C(C)=CC(CNC2CC3=CC=CC=C3C2)=C1C INGYUALHKPXCGN-UHFFFAOYSA-N 0.000 description 1
- KFMCDPVJVDHADX-UHFFFAOYSA-N 4-[(2,3-dihydro-1h-inden-2-ylamino)methyl]-2,6-dimethoxyphenol;hydrochloride Chemical compound Cl.COC1=C(O)C(OC)=CC(CNC2CC3=CC=CC=C3C2)=C1 KFMCDPVJVDHADX-UHFFFAOYSA-N 0.000 description 1
- BGRZUNXGMVUYMA-UHFFFAOYSA-N 4-[(2,3-dihydro-1h-inden-2-ylamino)methyl]-2-methyl-5-propan-2-ylphenol;hydrochloride Chemical compound Cl.CC(C)C1=CC(O)=C(C)C=C1CNC1CC2=CC=CC=C2C1 BGRZUNXGMVUYMA-UHFFFAOYSA-N 0.000 description 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- 125000003352 4-tert-butyl benzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])*)C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- KZTOPSLDJIJIPH-UHFFFAOYSA-N 6,7,8,9-tetrahydro-5h-benzo[7]annulen-6-amine;hydrochloride Chemical compound [Cl-].C1C([NH3+])CCCC2=CC=CC=C21 KZTOPSLDJIJIPH-UHFFFAOYSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000282693 Cercopithecidae Species 0.000 description 1
- 239000004380 Cholic acid Substances 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 239000002841 Lewis acid Substances 0.000 description 1
- 239000012448 Lithium borohydride Substances 0.000 description 1
- JLTDJTHDQAWBAV-UHFFFAOYSA-N N,N-dimethylaniline Chemical compound CN(C)C1=CC=CC=C1 JLTDJTHDQAWBAV-UHFFFAOYSA-N 0.000 description 1
- ZYWHRUVLAJAFSH-UHFFFAOYSA-N N-benzyl-4,6-dimethyl-2,3-dihydro-1H-inden-2-amine hydrochloride Chemical compound Cl.C(C1=CC=CC=C1)NC1CC2=CC(=CC(=C2C1)C)C ZYWHRUVLAJAFSH-UHFFFAOYSA-N 0.000 description 1
- VECWGARHUCQTAM-UHFFFAOYSA-N N-benzyl-6,7,8,9-tetrahydro-5H-benzo[7]annulen-6-amine hydrochloride Chemical compound Cl.C(C1=CC=CC=C1)NC1CC2=C(CCC1)C=CC=C2 VECWGARHUCQTAM-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 239000007868 Raney catalyst Substances 0.000 description 1
- NPXOKRUENSOPAO-UHFFFAOYSA-N Raney nickel Chemical compound [Al].[Ni] NPXOKRUENSOPAO-UHFFFAOYSA-N 0.000 description 1
- 229910000564 Raney nickel Inorganic materials 0.000 description 1
- 238000003436 Schotten-Baumann reaction Methods 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- SORGEQQSQGNZFI-UHFFFAOYSA-N [azido(phenoxy)phosphoryl]oxybenzene Chemical compound C=1C=CC=CC=1OP(=O)(N=[N+]=[N-])OC1=CC=CC=C1 SORGEQQSQGNZFI-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 125000005605 benzo group Chemical group 0.000 description 1
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001728 carbonyl compounds Chemical class 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
- 230000001906 cholesterol absorption Effects 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 229960002471 cholic acid Drugs 0.000 description 1
- 235000019416 cholic acid Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 108010011222 cyclo(Arg-Pro) Proteins 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 description 1
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- GGSUCNLOZRCGPQ-UHFFFAOYSA-N diethylaniline Chemical compound CCN(CC)C1=CC=CC=C1 GGSUCNLOZRCGPQ-UHFFFAOYSA-N 0.000 description 1
- 125000001028 difluoromethyl group Chemical group [H]C(F)(F)* 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 125000005982 diphenylmethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])(*)C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- MKRTXPORKIRPDG-UHFFFAOYSA-N diphenylphosphoryl azide Chemical compound C=1C=CC=CC=1P(=O)(N=[N+]=[N-])C1=CC=CC=C1 MKRTXPORKIRPDG-UHFFFAOYSA-N 0.000 description 1
- HCUYBXPSSCRKRF-UHFFFAOYSA-N diphosgene Chemical compound ClC(=O)OC(Cl)(Cl)Cl HCUYBXPSSCRKRF-UHFFFAOYSA-N 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000012156 elution solvent Substances 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- MOTRZVVGCFFABN-UHFFFAOYSA-N hexane;2-propan-2-yloxypropane Chemical compound CCCCCC.CC(C)OC(C)C MOTRZVVGCFFABN-UHFFFAOYSA-N 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 230000000260 hypercholesteremic effect Effects 0.000 description 1
- UMJJFEIKYGFCAT-UHFFFAOYSA-N indan-2-one Chemical compound C1=CC=C2CC(=O)CC2=C1 UMJJFEIKYGFCAT-UHFFFAOYSA-N 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- OWFXIOWLTKNBAP-UHFFFAOYSA-N isoamyl nitrite Chemical compound CC(C)CCON=O OWFXIOWLTKNBAP-UHFFFAOYSA-N 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 150000007517 lewis acids Chemical class 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 1
- 230000003228 microsomal effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- HBAMMUUNUCCRAB-UHFFFAOYSA-N n-(2-methyl-1-phenylpropyl)-2,3-dihydro-1h-inden-2-amine Chemical compound C1C2=CC=CC=C2CC1NC(C(C)C)C1=CC=CC=C1 HBAMMUUNUCCRAB-UHFFFAOYSA-N 0.000 description 1
- VMRGOFPYPSEYED-UHFFFAOYSA-N n-(2-phenylethyl)-2,3-dihydro-1h-inden-2-amine;hydrochloride Chemical compound Cl.C1C2=CC=CC=C2CC1NCCC1=CC=CC=C1 VMRGOFPYPSEYED-UHFFFAOYSA-N 0.000 description 1
- GGWWAVWHWIGLGX-UHFFFAOYSA-N n-(4,6-dimethyl-2,3-dihydro-1h-inden-2-yl)benzamide Chemical compound C1C=2C(C)=CC(C)=CC=2CC1NC(=O)C1=CC=CC=C1 GGWWAVWHWIGLGX-UHFFFAOYSA-N 0.000 description 1
- YYDWTYSHONGVEW-UHFFFAOYSA-N n-(pyridin-2-ylmethyl)-2,3-dihydro-1h-inden-2-amine;dihydrochloride Chemical compound Cl.Cl.C1C2=CC=CC=C2CC1NCC1=CC=CC=N1 YYDWTYSHONGVEW-UHFFFAOYSA-N 0.000 description 1
- KHKGKTXZCZYQRO-UHFFFAOYSA-N n-(thiophen-2-ylmethyl)-2,3-dihydro-1h-inden-2-amine;hydrochloride Chemical compound Cl.C1C2=CC=CC=C2CC1NCC1=CC=CS1 KHKGKTXZCZYQRO-UHFFFAOYSA-N 0.000 description 1
- SULDORBYWGINDH-UHFFFAOYSA-N n-[(2,4-dimethylphenyl)methyl]-2,3-dihydro-1h-inden-2-amine;hydrochloride Chemical compound Cl.CC1=CC(C)=CC=C1CNC1CC2=CC=CC=C2C1 SULDORBYWGINDH-UHFFFAOYSA-N 0.000 description 1
- OELVAXQOQHPXDW-UHFFFAOYSA-N n-[(2,5-dimethylphenyl)methyl]-2,3-dihydro-1h-inden-2-amine;hydrochloride Chemical compound Cl.CC1=CC=C(C)C(CNC2CC3=CC=CC=C3C2)=C1 OELVAXQOQHPXDW-UHFFFAOYSA-N 0.000 description 1
- RXUGLCBQZWKFSD-UHFFFAOYSA-N n-[(2-methylphenyl)methyl]-2,3-dihydro-1h-inden-2-amine;hydrochloride Chemical compound Cl.CC1=CC=CC=C1CNC1CC2=CC=CC=C2C1 RXUGLCBQZWKFSD-UHFFFAOYSA-N 0.000 description 1
- UUJZLVPWNWLBGY-UHFFFAOYSA-N n-[(3,4-dimethoxyphenyl)methyl]-2,3-dihydro-1h-inden-2-amine;hydrochloride Chemical compound Cl.C1=C(OC)C(OC)=CC=C1CNC1CC2=CC=CC=C2C1 UUJZLVPWNWLBGY-UHFFFAOYSA-N 0.000 description 1
- GXPIPAIXYOBANG-UHFFFAOYSA-N n-[(4-chlorophenyl)methyl]-2,3-dihydro-1h-inden-2-amine;hydrochloride Chemical compound Cl.C1=CC(Cl)=CC=C1CNC1CC2=CC=CC=C2C1 GXPIPAIXYOBANG-UHFFFAOYSA-N 0.000 description 1
- SRHLONYSCJNXIN-UHFFFAOYSA-N n-[(4-methoxy-2,5-dimethylphenyl)methyl]-2,3-dihydro-1h-inden-2-amine;hydrochloride Chemical compound Cl.C1=C(C)C(OC)=CC(C)=C1CNC1CC2=CC=CC=C2C1 SRHLONYSCJNXIN-UHFFFAOYSA-N 0.000 description 1
- VVKNTYYRJCKJTO-UHFFFAOYSA-N n-[(4-methylphenyl)methyl]-2,3-dihydro-1h-inden-2-amine;hydrochloride Chemical compound Cl.C1=CC(C)=CC=C1CNC1CC2=CC=CC=C2C1 VVKNTYYRJCKJTO-UHFFFAOYSA-N 0.000 description 1
- NDGJQTMULQQURY-UHFFFAOYSA-N n-[(4-methylsulfanylphenyl)methyl]-2,3-dihydro-1h-inden-2-amine;hydrochloride Chemical compound Cl.C1=CC(SC)=CC=C1CNC1CC2=CC=CC=C2C1 NDGJQTMULQQURY-UHFFFAOYSA-N 0.000 description 1
- FFSWSMMNVOGUOR-UHFFFAOYSA-N n-[(4-propan-2-ylphenyl)methyl]-2,3-dihydro-1h-inden-2-amine;hydrochloride Chemical compound Cl.C1=CC(C(C)C)=CC=C1CNC1CC2=CC=CC=C2C1 FFSWSMMNVOGUOR-UHFFFAOYSA-N 0.000 description 1
- CYZSWXDFAUHCRD-UHFFFAOYSA-N n-benzhydryl-2,3-dihydro-1h-inden-2-amine Chemical compound C1C2=CC=CC=C2CC1NC(C=1C=CC=CC=1)C1=CC=CC=C1 CYZSWXDFAUHCRD-UHFFFAOYSA-N 0.000 description 1
- OWIZYZJDRLPDDD-UHFFFAOYSA-N n-benzyl-2,3-dihydro-1h-inden-1-amine;hydrochloride Chemical compound Cl.C1CC2=CC=CC=C2C1NCC1=CC=CC=C1 OWIZYZJDRLPDDD-UHFFFAOYSA-N 0.000 description 1
- QYBIZZCHZXZBFQ-UHFFFAOYSA-N n-benzyl-2,3-dihydro-1h-inden-2-amine;hydrochloride Chemical compound Cl.C1C2=CC=CC=C2CC1NCC1=CC=CC=C1 QYBIZZCHZXZBFQ-UHFFFAOYSA-N 0.000 description 1
- MXLFYAYMKHYZKD-UHFFFAOYSA-N n-benzyl-3,4-dihydro-2h-thiochromen-4-amine;hydrochloride Chemical compound Cl.C1CSC2=CC=CC=C2C1NCC1=CC=CC=C1 MXLFYAYMKHYZKD-UHFFFAOYSA-N 0.000 description 1
- CIRDMOSCTWODDN-UHFFFAOYSA-N n-benzyl-4,5,6-trimethoxy-2,3-dihydro-1h-inden-2-amine;hydrochloride Chemical compound Cl.C1C=2C(OC)=C(OC)C(OC)=CC=2CC1NCC1=CC=CC=C1 CIRDMOSCTWODDN-UHFFFAOYSA-N 0.000 description 1
- RGFGYHZDXMZBNP-UHFFFAOYSA-N n-benzyl-7-chloro-3,4-dihydro-2h-chromen-4-amine;hydrochloride Chemical compound Cl.C1COC2=CC(Cl)=CC=C2C1NCC1=CC=CC=C1 RGFGYHZDXMZBNP-UHFFFAOYSA-N 0.000 description 1
- MHVHCDLCLNXADJ-UHFFFAOYSA-N n-phenyl-2,3-dihydro-1h-inden-2-amine Chemical compound C1C2=CC=CC=C2CC1NC1=CC=CC=C1 MHVHCDLCLNXADJ-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- XDUHQPOXLUAVEE-BPMMELMSSA-N oleoyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCCCCCC\C=C/CCCCCCCC)O[C@H]1N1C2=NC=NC(N)=C2N=C1 XDUHQPOXLUAVEE-BPMMELMSSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- KJIFKLIQANRMOU-UHFFFAOYSA-N oxidanium;4-methylbenzenesulfonate Chemical compound O.CC1=CC=C(S(O)(=O)=O)C=C1 KJIFKLIQANRMOU-UHFFFAOYSA-N 0.000 description 1
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 1
- 125000006340 pentafluoro ethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 229960004838 phosphoric acid Drugs 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229910003446 platinum oxide Inorganic materials 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 229940086066 potassium hydrogencarbonate Drugs 0.000 description 1
- 239000012254 powdered material Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- AAZYNPCMLRQUHI-UHFFFAOYSA-N propan-2-one;2-propan-2-yloxypropane Chemical compound CC(C)=O.CC(C)OC(C)C AAZYNPCMLRQUHI-UHFFFAOYSA-N 0.000 description 1
- 229940043274 prophylactic drug Drugs 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229940032330 sulfuric acid Drugs 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 229940126585 therapeutic drug Drugs 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 125000003866 trichloromethyl group Chemical group ClC(Cl)(Cl)* 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
Landscapes
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Abstract
Description
【発明の詳細な説明】
「産業上の利用分野」
本発明は優れたアシルCoA:コレステロールアシルト
ランスフェラーゼ(A CA T )阻害作用ヲ有する
新規なベンゾシクロアルカン誘導体に関する。DETAILED DESCRIPTION OF THE INVENTION "Industrial Application Field" The present invention relates to a novel benzocycloalkane derivative having an excellent acyl-CoA:cholesterol acyltransferase (A CAT ) inhibitory effect.
本発明の化合物は哺乳動物においてコレステロールの腸
管からの吸収を阻害し、動脈壁でのコレステロールエス
テルの蓄積を抑制するので、高コレステロール血症、ア
テローム性動脈硬化症及びこれらに起因する各種疾患(
例、心筋梗塞などの虚血性心疾患及び脳梗塞、脳卒中な
どの脳血管障害など)の予防、治療薬として有用である
。The compounds of the present invention inhibit the absorption of cholesterol from the intestinal tract in mammals and suppress the accumulation of cholesterol esters in the arterial walls, resulting in hypercholesterolemia, atherosclerosis, and various diseases caused by these.
For example, it is useful as a prophylactic or therapeutic drug for ischemic heart disease such as myocardial infarction and cerebrovascular disorders such as cerebral infarction and stroke.
「従来の技術」
特開昭63−316761.特開平1−93569、米
国特許No、4.623,662には、ACAT阻害作
用を有する尿素誘導体が開示されいてるが、尿素の窒素
原子にベンゾシクロアルキル基が直接置換した誘導体は
全く合成されていない。"Prior art" JP-A-63-316761. JP-A-1-93569 and U.S. Patent No. 4,623,662 disclose urea derivatives that have an ACAT inhibitory effect, but no derivatives in which the nitrogen atom of urea is directly substituted with a benzocycloalkyl group have been synthesized. do not have.
「発明が解決しようとする課題」
尿1の窒素原子にベンゾシクロアルキル基が直接置換し
た化合物で、優れたACAT阻害作用、血中コレステロ
ール低下作用を有し、動脈硬化用剤として有用なものは
今迄に見出されていなかった。"Problem to be Solved by the Invention" A compound in which the nitrogen atom of urine 1 is directly substituted with a benzocycloalkyl group, which has an excellent ACAT inhibiting effect and a blood cholesterol lowering effect, and is useful as an agent for arteriosclerosis. It had not been discovered until now.
「課題を解決するための手段」
本発明者らは、窒素原子にベンゾシクロアルキル基が直
接置換した新規な尿素誘導体を種々合成してその活性に
つき鋭意検討した結果、−数式[式中、RはHまたは置
換基を有していてもよい炭化水素基を、Arは芳香環基
を、Xは酸素原子またはイオウ原子を、gは0または1
を、mは3〜6を、nは0〜2を示し、A環及びArは
それぞれ置換基を有していてもよい。コて表わされる新
規なベンゾシクロアルカン誘導体またはそ)塩カ、優れ
たACAT阻害作用を有していることを見出し、これに
基づいて本発明を完成した。"Means for Solving the Problems" As a result of synthesizing various novel urea derivatives in which the nitrogen atom is directly substituted with a benzocycloalkyl group and intensively examining their activities, the present inventors found that - formula [wherein R represents H or a hydrocarbon group that may have a substituent, Ar represents an aromatic ring group, X represents an oxygen atom or a sulfur atom, and g represents 0 or 1.
, m represents 3 to 6, n represents 0 to 2, and the A ring and Ar may each have a substituent. The present invention was completed based on the discovery that the novel benzocycloalkane derivative or salt thereof has an excellent ACAT inhibitory effect.
即ち、本発明は、
(1)−数式(1)で表わされる新規ベンゾ/りaアル
カン誘導体またはその塩、
(2)上記(I)の新規ベンゾシクロアルカン誘導体の
製造法、
(3)化合物(1)を含有してなるACAT阻害剤、に
関するものである。That is, the present invention provides (1) a novel benzo/ria alkane derivative represented by formula (1) or a salt thereof, (2) a method for producing the novel benzocycloalkane derivative of (I) above, (3) a compound ( The present invention relates to an ACAT inhibitor containing 1).
一般式(r)中RはHまたは置換基を有していてもよい
炭化水素基を示す。Rで示される炭化水素基としては、
たとえばアルキル、アリール、アラルキル基等が用いら
れる。Rで示されるアルキル基としては、たとえば炭素
数1〜8の直鎖状、分枝状または環状のものが好ましく
、例えばメチル。In the general formula (r), R represents H or a hydrocarbon group which may have a substituent. The hydrocarbon group represented by R is
For example, alkyl, aryl, aralkyl groups, etc. are used. The alkyl group represented by R is preferably a linear, branched or cyclic group having 1 to 8 carbon atoms, such as methyl.
エチル、プロピル、イソプロピル、シクロプロピル、ブ
チル、イソブチル、 5ee−ブチル、 tert −
ブチル、シクロプロピルメチル、ペンチル、イソペンチ
ル、ネオペンチル、シクロペンチル、ヘキシル、シクロ
ヘキシル、ヘプチル、シクロヘキシルメチル、オクチル
などが用いられる。Rで示されるアリール基としては、
たとえばフェニル、ナフチル等の炭素数6〜lOのアリ
ール基が好ましい。Rで示されるアラルキル基としては
、たとえばベンジル、1−フェニルエチル、2−フェニ
ルエチル、■−フェニルプロピル、2−フェニルプロピ
ル、3−フェニルプロピル、ジフェニルメチル、 O
,S+またはp−メチルベンジル、o、mまたはpエチ
ルベンジル、 o、mまたはp−インプロピルベンジ
ル、01mまたはp−tert−ブチルベンジル2.3
−.2.4−.2.5−.2.6−.3.4−または3
.5−ジメチルベンジル、2,3.4−3.4.5−ま
たは2.4.6−ドリメチルベンジル。Ethyl, propyl, isopropyl, cyclopropyl, butyl, isobutyl, 5ee-butyl, tert-
Butyl, cyclopropylmethyl, pentyl, isopentyl, neopentyl, cyclopentyl, hexyl, cyclohexyl, heptyl, cyclohexylmethyl, octyl, and the like are used. The aryl group represented by R is
For example, aryl groups having 6 to 10 carbon atoms such as phenyl and naphthyl are preferred. Examples of the aralkyl group represented by R include benzyl, 1-phenylethyl, 2-phenylethyl, ■-phenylpropyl, 2-phenylpropyl, 3-phenylpropyl, diphenylmethyl, O
, S+ or p-methylbenzyl, o, m or p-ethylbenzyl, o, m or p-inpropylbenzyl, 01m or p-tert-butylbenzyl 2.3
−. 2.4-. 2.5-. 2.6-. 3.4-or 3
.. 5-dimethylbenzyl, 2,3.4-3.4.5- or 2.4.6-dimethylbenzyl.
5−イソプロピル−2−メチルベンジル、2−イソプロ
ピル−5−メチルベンジル、2−メチル−5−tert
−ブチルベンジル、2.4−.2.5−または3.5−
ジイソプロピルベンジル、3,5−ジー tert−ブ
チルベンジル、1−(2−メチルフェニル)エチル、1
−(3−メチルフェニル)エチル。5-isopropyl-2-methylbenzyl, 2-isopropyl-5-methylbenzyl, 2-methyl-5-tert
-butylbenzyl, 2.4-. 2.5- or 3.5-
Diisopropylbenzyl, 3,5-di-tert-butylbenzyl, 1-(2-methylphenyl)ethyl, 1
-(3-methylphenyl)ethyl.
1−(4−メチルフェニル)エチル、1−(2−イソプ
ロピルフェニル)エチル、1−(3−イソプロピルフェ
ニル)エチル、1−(4−イソプロピルフェニル)エチ
ル、l (2−tert−ブチルフェニル)エチル、
1 (4−tert−ブチルフェニル)エチル。1-(4-methylphenyl)ethyl, 1-(2-isopropylphenyl)ethyl, 1-(3-isopropylphenyl)ethyl, 1-(4-isopropylphenyl)ethyl, l(2-tert-butylphenyl)ethyl ,
1 (4-tert-butylphenyl)ethyl.
1−(2−イソプロピル−4−メチルフェニル)エチル
、1−(4−イソプロピル−2−メチルフェニル)エチ
ル、1−(2,4−ジメチルフェニル)エチル、1−(
2,5−ジメチルフェニル)エチル。1-(2-isopropyl-4-methylphenyl)ethyl, 1-(4-isopropyl-2-methylphenyl)ethyl, 1-(2,4-dimethylphenyl)ethyl, 1-(
2,5-dimethylphenyl)ethyl.
1−(3,5−ジメチルフェニル)エチル、1−(3゜
5−ジーtert−ブチルフェニル)エチルなど炭素数
7〜16個のアラルキル基等が好ましい。さらにこれら
のRで示される炭化水素基は、同一または相異なる置換
基をl〜5個有していてもよい。Aralkyl groups having 7 to 16 carbon atoms, such as 1-(3,5-dimethylphenyl)ethyl and 1-(3°5-di-tert-butylphenyl)ethyl, are preferred. Furthermore, these hydrocarbon groups represented by R may have 1 to 5 substituents that are the same or different.
この様な置換基としてはたとえばハロゲン、ハロゲン化
されていてもよい低級アルコキシ基、ハロゲン化されて
いてもよい低級アルキルチオ基、ニトロ基、エステル化
されていてもよいカルボキシル基、水酸基、C1−3ア
シル基(たとえばホルミル、アセチル、プロピオニル等
)、複素環基等が用いられる。このような置換基として
のハロゲンの例としてはフッ素、塩素、臭素及びヨウ素
が用いられる。ハロゲン化されてゝいてもよい低級アル
コキシ及びハロゲン化されていてもよい低級アルキルチ
オ基としては、たとえばハロゲン(フッ素、塩素、臭素
又はヨウ素)化されていてもよい炭素数1〜6の直鎖状
または分枝状の低級アルキル基(たとえばメチル、エチ
ル、プロピル、イソプロピル。Examples of such substituents include halogen, an optionally halogenated lower alkoxy group, an optionally halogenated lower alkylthio group, a nitro group, an optionally esterified carboxyl group, a hydroxyl group, and a C1-3 Acyl groups (eg, formyl, acetyl, propionyl, etc.), heterocyclic groups, etc. are used. Examples of halogen as such a substituent include fluorine, chlorine, bromine and iodine. The optionally halogenated lower alkoxy and optionally halogenated lower alkylthio groups include, for example, straight-chain groups having 1 to 6 carbon atoms that may be halogenated (fluorine, chlorine, bromine or iodine). or branched lower alkyl groups (e.g. methyl, ethyl, propyl, isopropyl).
ブチル、イソブチル、 5ec−ブチル、 tert−
ブチル、ペンチル、インペンチル、ヘキシル等)ト、そ
れぞれ酸素原子及び硫黄原子とが結合してできるハロゲ
ン化されていてもよい低級アルコキシ、ハロゲン化され
ていてもよい低級アルキルチオ基などが用いられる。ま
たエステル化されていてもよいカルボキシル基としては
、たとえばメチル、エチル、プロピル、イソプロピル、
ブチル、イソブチル、5ec−ブチル、tert−ブチ
ル、ペンチル、ヘキシルなどの炭素数1〜6のアルキル
基でエステル化されたカルボキシル基等が用いられる。Butyl, isobutyl, 5ec-butyl, tert-
(butyl, pentyl, impentyl, hexyl, etc.), an optionally halogenated lower alkoxy group formed by bonding to an oxygen atom and a sulfur atom, and an optionally halogenated lower alkylthio group. Examples of carboxyl groups that may be esterified include methyl, ethyl, propyl, isopropyl,
A carboxyl group esterified with an alkyl group having 1 to 6 carbon atoms, such as butyl, isobutyl, 5ec-butyl, tert-butyl, pentyl, and hexyl, is used.
複素環基としては、好ましくはへテロ原子として窒素、
イオウまたは酸素原子等を含む複素環基で、たとえば2
または3−チエニル、2または3−フリル、2,3また
は4−ピリジル基等の5又は6員の芳香性複素環基等が
用いられる。Rの好ましい例は、たとえば置換基を有し
ていてもよいベンジル基であり、特にたとえばCI−4
アルキル(たとえばメチル、エチル、プロピル、イソプ
ロピル、ブチル、イソブチル、8ec−ブチル、ter
t−ブチル等)または水酸基等で1〜2個置換されてい
てもよいベンジル基が繁用される。又、Rが水酸基で置
換された炭化水素基(特にベンジル基等)である場合、
目的物(1)は抗酸化作用をも示す。The heterocyclic group preferably contains nitrogen as a heteroatom,
A heterocyclic group containing a sulfur or oxygen atom, for example 2
Alternatively, a 5- or 6-membered aromatic heterocyclic group such as 3-thienyl, 2- or 3-furyl, 2, 3- or 4-pyridyl group, etc. can be used. A preferred example of R is, for example, a benzyl group which may have a substituent, particularly, for example, CI-4
Alkyl (e.g. methyl, ethyl, propyl, isopropyl, butyl, isobutyl, 8ec-butyl, ter
(t-butyl, etc.) or a benzyl group which may be substituted with one or two hydroxyl groups, etc., is often used. In addition, when R is a hydrocarbon group substituted with a hydroxyl group (especially a benzyl group, etc.),
Target compound (1) also exhibits antioxidant activity.
Arは芳香環基を示し、芳香環基としては芳香性の同素
又は複素環基が用いられる。芳香性の同素環基としては
、上記で述べたごときアリール基が、又芳香性の複素環
基としては上記で述べたごとき5又は6員の芳香性複素
環基が用いられる。Ar represents an aromatic ring group, and an aromatic isocyclic or heterocyclic group is used as the aromatic ring group. As the aromatic homocyclic group, the above-mentioned aryl group is used, and as the aromatic heterocyclic group, the above-mentioned 5- or 6-membered aromatic heterocyclic group is used.
またA環及び上記Arは置換基を有していてもよく、こ
の様な置換基は、それぞれの環のいずれの位置に置換し
ていてもよく、かつそれぞれ同一または異って1〜5個
置換していてもよい。A環及びArで用いられる置換基
としては、上記Rで述べた炭化水素基の置換基が用いら
れるほか、ノ\ロゲン化されていてもよい低級アルキル
基、たとえば炭素数1〜6の直鎖状または分枝状の低級
アルキル基及びこれにハロゲン原子2〜5個の置換した
もの等が用いられ、たとえばメチル、クロロメチル、ジ
フルオロメチル、トリクロロメチル、トリフルオロメチ
ル、エチル、2−ブロモエチル、2.2.2−トリフル
オロエチル、ペンタフルオロエチル、プロピル、3.3
.3−トリフルオロエチル、イソプロピル、2−トリフ
ルすロメチルエチル、ブチル、4,4.4−トリフルオ
ロブチル、イソブチル、5ec−ブチル、tert−ブ
チル、ペンチル、インペンチル、ネオペンチル、5,5
.5−トリフルオロペンチル、4−トリフルオロメチル
ブチル、ヘキシル、6,6.ロートリフルオロヘキシル
、5−トリフルオロヘキシル、5−トリフルオロメチル
ペンチルなどが繁用される。Arの好ましい例としては
、ハロゲン(たとえばF等)で1〜2個置換されていて
もよいフェニル基等が用いられる。A環は無置換のもの
が好ましい。In addition, the A ring and the above Ar may have a substituent, and such substituents may be substituted at any position of each ring, and 1 to 5 of them may be the same or different. May be replaced. As the substituents used in the A ring and Ar, in addition to the substituents for the hydrocarbon groups mentioned above for R, lower alkyl groups that may be halogenated, such as straight chain carbon atoms of 1 to 6 Shaped or branched lower alkyl groups and those substituted with 2 to 5 halogen atoms are used, such as methyl, chloromethyl, difluoromethyl, trichloromethyl, trifluoromethyl, ethyl, 2-bromoethyl, .2.2-Trifluoroethyl, pentafluoroethyl, propyl, 3.3
.. 3-trifluoroethyl, isopropyl, 2-trifluoromethylethyl, butyl, 4,4.4-trifluorobutyl, isobutyl, 5ec-butyl, tert-butyl, pentyl, impentyl, neopentyl, 5,5
.. 5-trifluoropentyl, 4-trifluoromethylbutyl, hexyl, 6,6. Rotrifluorohexyl, 5-trifluorohexyl, 5-trifluoromethylpentyl, etc. are frequently used. A preferable example of Ar is a phenyl group which may be substituted with one or two halogens (for example, F, etc.). Ring A is preferably unsubstituted.
nは0のものが好ましい。Preferably, n is 0.
Qは0または1を、mは3〜6を示し、等を示す。Q represents 0 or 1, m represents 3 to 6, etc.
一般式(1)で表わされるベンゾシクロアルカン誘導体
は、Rで示される炭化水素基が薬学的に許容しうる塩、
例えば、カルシウム塩、ナトリウム塩などのアルカリ金
属塩であってもよい。The benzocycloalkane derivative represented by the general formula (1) is a pharmaceutically acceptable salt of the hydrocarbon group represented by R,
For example, it may be an alkali metal salt such as a calcium salt or a sodium salt.
一般式(I)で表わされるベンゾシクロアルカン誘導体
またはその塩は、たとえば一般式で表わされる化合物ま
たはその塩と一般式A r (CH−)nN CO(
DI )で表わされる化合物とを反応させる[上記式中
記号は前記と同意義を示す。コことにより製造すること
ができる。The benzocycloalkane derivative represented by the general formula (I) or a salt thereof is, for example, a combination of a compound represented by the general formula or a salt thereof and the general formula A r (CH-)nN CO (
DI ) [Symbols in the above formula have the same meanings as above. It can be manufactured by
アミノベンゾシクロアルカン誘導体(II)の塩として
は、たとえば塩酸、臭化水素酸、硫酸、リン酸、メタン
スルホン酸、ベンゼンスルホン酸、p−トルエンスルホ
ン酸、フマール酸、マレイン酸、クエン酸、酒石酸等の
無機酸または有機酸との塩等が用いられる。本反応は通
常適宜の溶媒中で行なわれる。使用される溶媒は反応に
不活性なものであればいかなる溶媒でもよく、たとえば
エチルエーテル、イソプロピルエーテル、ジメトキシエ
タン、テトラヒドロフラン、ジオキサンなどのエーテル
類、ベンゼン、トルエン、キシレンなどの芳香族炭化水
素類、酢酸メチル、酢酸エチルなどのエステル類、アセ
トン、メチルエチルケトン等のケトン類、ジクロルメタ
ン、クロロホルムなどのハロゲノ炭化水素類、ピリジン
、N、N−ジメチルホルムアミド、ジメチルスルホキシ
ドなどが用いられる。また(n)が塩として反応に用い
られる場合、通常塩基(例、トリメチルアミン、トリエ
チルアミン、ピリジン、ピコリン、ナトリウムメチラー
ト、ナトリウムエチラート、水酸化ナトリウム、水酸化
カリウム、炭酸ナトリウム、炭酸カリウムなど)の存在
下に脱塩することで反応は有意に進行する。かかる塩基
の使用量は(■〉1モルに対して1〜3モル当量好まし
くは1−1.5モル当量である。反応は通常−10℃〜
150℃、好ましくは0℃−80℃で行われる。(I[
[)の使用量は(II)に対し通常約1〜5当量、好ま
しくは1〜2当量である。反応時間は、用いられる原料
、溶媒、反応温度等により異なるが、通常5分〜24時
間、好ましくは10分〜6時間である。Examples of the salt of aminobenzocycloalkane derivative (II) include hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, methanesulfonic acid, benzenesulfonic acid, p-toluenesulfonic acid, fumaric acid, maleic acid, citric acid, and tartaric acid. Salts with inorganic acids or organic acids such as these are used. This reaction is usually carried out in an appropriate solvent. The solvent used may be any solvent as long as it is inert to the reaction, such as ethers such as ethyl ether, isopropyl ether, dimethoxyethane, tetrahydrofuran, and dioxane, aromatic hydrocarbons such as benzene, toluene, and xylene, Esters such as methyl acetate and ethyl acetate, ketones such as acetone and methyl ethyl ketone, halogenohydrocarbons such as dichloromethane and chloroform, pyridine, N,N-dimethylformamide, dimethyl sulfoxide, and the like are used. In addition, when (n) is used as a salt in the reaction, it is usually a base (e.g., trimethylamine, triethylamine, pyridine, picoline, sodium methylate, sodium ethylate, sodium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, etc.). The reaction proceeds significantly by desalting in the presence of the compound. The amount of the base used is (■) 1 to 3 molar equivalents, preferably 1 to 1.5 molar equivalents, per 1 mole.The reaction is usually carried out at -10°C to
It is carried out at 150°C, preferably between 0°C and 80°C. (I[
The amount of [) used is usually about 1 to 5 equivalents, preferably 1 to 2 equivalents, relative to (II). The reaction time varies depending on the raw materials, solvent, reaction temperature, etc. used, but is usually 5 minutes to 24 hours, preferably 10 minutes to 6 hours.
製造された化合物(1)中、A環、Ar及びRで示され
るベンゼン環に低級アルコキシ基が置換する場合、必要
により化合物(I)を反応混合物のままあるいは下記の
公知方法で単離後にさらにたとえば三臭化ホウ素などと
反応させることにより、低級アルコキシ基を水酸基に変
換することもできる。本反応は通常溶媒(例、ジクロル
メタン、クロロホルム、四塩化炭素などのハロゲノ炭化
水素類、ベンゼン、トルエンなどの芳香族炭化水素類等
)中約−20℃〜80℃、好ましくは一5℃〜30℃で
行われる。三臭化ホウ素の使用量は低級アルコキシ基1
個に対し、約1−10当量好ましくは約1〜5当量であ
る。In the produced compound (1), when the benzene ring represented by ring A, Ar or R is substituted with a lower alkoxy group, compound (I) may be further added as a reaction mixture or after isolation by the following known method, if necessary. For example, a lower alkoxy group can be converted into a hydroxyl group by reacting with boron tribromide or the like. This reaction is usually carried out in a solvent (e.g., halogenated hydrocarbons such as dichloromethane, chloroform, carbon tetrachloride, aromatic hydrocarbons such as benzene, toluene, etc.) at about -20°C to 80°C, preferably -5°C to 30°C. Performed at °C. The amount of boron tribromide used is 1 lower alkoxy group
The amount is about 1 to 10 equivalents, preferably about 1 to 5 equivalents.
得られた目的化合物(I)はそれ自体公知の分離精製手
段(例、濃縮、溶媒抽出、カラムクロマトグラフィー、
再結晶など)を用いることにより精製、採取することが
できる。The obtained target compound (I) can be purified by separation and purification means known per se (e.g., concentration, solvent extraction, column chromatography,
It can be purified and collected using methods such as recrystallization.
かくして得られる目的化合物(I)の好ましい例は、た
とえば一般式
[式中、Raは置換基を有していてもよいベンジル基を
、X、ff、mは前記と同意義を示す。]で表わされる
化合物またはその塩、一般式
[式中、Ra及び鑞は前記と同意義を示す。]で表わさ
れる化合物またはその塩等である。上記式中Raで示さ
れるベンジル基の置換基は、前記Rで述べた場合と同様
である。A preferable example of the target compound (I) thus obtained is, for example, a compound of the general formula [wherein Ra is a benzyl group which may have a substituent, and X, ff, and m have the same meanings as above. ] or a salt thereof, a compound represented by the general formula [wherein Ra and Arsen have the same meanings as above. ] or a salt thereof. The substituents of the benzyl group represented by Ra in the above formula are the same as those described for R above.
化合物(1)は優れたアシルCoA:コレステロールア
シルトランスフェラーゼ(ACAT)の阻害作用を有し
、かつ急性毒性、連続投与による毒性ともに弱い。AC
ATは細胞内でのコレステロールの高級脂肪酸エステル
化に関わる酵素で、小腸におけるコレステロールの吸収
及び細胞内でのコレステロールエステルの蓄積に重要な
役割ヲ果シていることが知られている。従って、ACA
T阻害剤は食事性コレステロールの腸管からの吸収を阻
害し、血中コレステロール値の上昇を抑制するとともに
、動脈硬化巣における細胞内コレステロールの蓄積を抑
え、粥状硬化の進展を妨げることができる。本発明化合
物(1)は従って哺乳動物(例、マウス、ラット、ハム
スター、ウサギ、ネコ、イヌ、ウマ、ウシ、ヒツジ、サ
ル、ヒトなど)における高コレステロール血症、アテロ
ーム性動脈硬化症及びこれらに起因する疾患(例、心筋
梗塞などの虚血性心疾患および脳梗塞、脳卒中などの脳
血管障害など)に対する安全な予防・治療剤として有用
である。Compound (1) has an excellent inhibitory effect on acyl-CoA:cholesterol acyltransferase (ACAT), and has low acute toxicity and low toxicity upon continuous administration. A.C.
AT is an enzyme involved in intracellular higher fatty acid esterification of cholesterol, and is known to play an important role in the absorption of cholesterol in the small intestine and the accumulation of cholesterol esters in cells. Therefore, the ACA
T inhibitors can inhibit the absorption of dietary cholesterol from the intestinal tract, suppress the rise in blood cholesterol levels, suppress the accumulation of intracellular cholesterol in arteriosclerotic lesions, and prevent the development of atherosclerosis. The compound (1) of the present invention can therefore be used to treat hypercholesterolemia, atherosclerosis, and other diseases in mammals (e.g., mice, rats, hamsters, rabbits, cats, dogs, horses, cows, sheep, monkeys, humans, etc.). It is useful as a safe prophylactic/therapeutic agent for diseases caused by it (eg, ischemic heart disease such as myocardial infarction, and cerebrovascular disorders such as cerebral infarction and stroke).
−数式(I)で表わされる化合物を上記の医薬品として
用いる場合、適宜の薬理学的に許容され得る担体、賦形
剤、希釈剤と混合し、粉末、顆粒、錠剤、カプセル剤、
注射剤などの形態で経口的または非経口的に投与するこ
とができるが、コレステロールの吸収阻害の目的に使用
するときは経口的に投与することがより好ましい。投与
量は化合物(I)の種類、投与ルート、症状、患者の年
令などによっても異るが、例えば成人の高コレステロー
ル血症患者に経口的に投与する場合、1日量は体重1k
gあたり約0.005〜100 mg、好ましくは約0
.05〜5C)+g、さらに好ましくは0.5〜10m
gで、この量を1日1〜3回に分割投与するのが好まし
い。- When the compound represented by formula (I) is used as the above pharmaceutical, it is mixed with appropriate pharmacologically acceptable carriers, excipients, and diluents to form powders, granules, tablets, capsules,
Although it can be administered orally or parenterally in the form of an injection, it is more preferable to administer it orally when used for the purpose of inhibiting cholesterol absorption. The dosage varies depending on the type of compound (I), administration route, symptoms, age of the patient, etc., but for example, when administered orally to an adult hypercholesterolemic patient, the daily dose is 1 kg body weight.
About 0.005-100 mg per g, preferably about 0
.. 05~5C)+g, more preferably 0.5~10m
g, and this amount is preferably administered in divided doses from 1 to 3 times a day.
本発明化合物(I)を製造するための原料化6物は、例
えばつぎのようにして自体公知の方法で製造することが
できる。The six raw materials for producing the compound (I) of the present invention can be produced by a method known per se, for example, as follows.
[A 法]
(1’V)
(n)
[式中の記号は前記と同意義を示す。][B 法]
[式中、R’、R”は水素または置換基を有していても
よい炭化水素基を、他の記号は前記と同意義を示すコ。[Method A] (1'V) (n) [Symbols in the formula have the same meanings as above. [Method B] [In the formula, R' and R'' represent hydrogen or a hydrocarbon group which may have a substituent, and other symbols have the same meanings as above.
[C法] [式中の各記号は前記と同意義を示すコ。[C method] [Each symbol in the formula has the same meaning as above.
[A 法]
ベンゾシクロアルカノン(IV)によるアミン(V)の
還元アルキル化反応は通常溶媒中で行うことができる。[Method A] The reductive alkylation reaction of amine (V) with benzocycloalkanone (IV) can usually be carried out in a solvent.
使用される溶媒は反応に不活性なものであればいかなる
溶媒でもよく、例えばメタノール、エタノール、イソプ
ロパツールなどのアルコール類、エチルエーテル、イソ
プロピルエーテル、ジメトキ°シエタン、テトラヒドロ
フラン、ジオキサンなどのエーテル類、ベンゼン、トル
エン、キシレンなどの芳香族炭化水素類、ジメチルホル
ムアミド、ジメチルスルホキシドなどが用いられる。The solvent used may be any solvent as long as it is inert to the reaction, such as alcohols such as methanol, ethanol, and isopropanol; ethers such as ethyl ether, isopropyl ether, dimethoxyethane, tetrahydrofuran, and dioxane; Aromatic hydrocarbons such as benzene, toluene, and xylene, dimethylformamide, and dimethyl sulfoxide are used.
またこれらの混合溶媒を用いてもよい。本反応に使用さ
れる還元剤は、たとえば水素化ホウ素ナトリウム、水素
化ホウ素リチウム、シアノ水素化ホウ素ナトリウム、水
素化リチウムアルミニウム等であり、通常(■)1モル
に対して0.5〜5モル好ましくは0.5〜2モルが用
いられる。かかる還元反応は通常−10℃〜150℃好
ましくは5°C〜100℃で行うことができる。反応時
間は、通常15分〜24時間好ましくは30分〜8時間
である。A mixed solvent of these may also be used. The reducing agent used in this reaction is, for example, sodium borohydride, lithium borohydride, sodium cyanoborohydride, lithium aluminum hydride, etc., and is usually (■) 0.5 to 5 mol per 1 mol. Preferably 0.5 to 2 mol is used. Such a reduction reaction can be carried out normally at -10°C to 150°C, preferably at 5°C to 100°C. The reaction time is usually 15 minutes to 24 hours, preferably 30 minutes to 8 hours.
本反応は上記還元剤を用いる他に適当な触媒を用いる接
触還元を用いて行ってもよい。かかる触媒としてはたと
えばパラジウム黒、パラジウム−炭素、塩化パラジウム
等のパラジウム系触媒、酸化白金、白金黒などの白金系
触媒、ラネーニッケル等が用いられる。触媒量は通常(
■)1モルに対して0.001〜2モル、好ましくはo
、oiモル〜1モルが用いられる。反応圧力は1〜10
0気圧/c+a’、好ましくは1〜20気圧/cm”で
行われる。かかる還元反応は通常−10’C〜150°
C1好ましくは一り℃〜I00’Cで行うことができる
。In addition to using the above-mentioned reducing agent, this reaction may also be carried out using catalytic reduction using a suitable catalyst. Examples of such catalysts include palladium-based catalysts such as palladium black, palladium-carbon and palladium chloride, platinum-based catalysts such as platinum oxide and platinum black, and Raney nickel. The amount of catalyst is usually (
■) 0.001 to 2 mol per mol, preferably o
, oi mol to 1 mol are used. The reaction pressure is 1-10
The reduction reaction is carried out at 0 atm/c+a', preferably 1 to 20 atm/cm". Such a reduction reaction is usually carried out at -10'C to 150°C.
C1 Preferably, it can be carried out at 1°C to 100'C.
また、反応時間は、通常30分〜12時間好ましくは3
0分〜5時間である。Further, the reaction time is usually 30 minutes to 12 hours, preferably 3 hours.
It is 0 minutes to 5 hours.
上述の還元反応及び接触還元反応は酸触媒の存在下に反
応を促進させてもよい。本酸触媒としては、たとえばギ
酸、酢酸、プロピオン酸、トリフルオロ酢酸、メタンス
ルホン酸、ベンゼンスルホンM、p−トルエンスルホン
酸、カンファースルホン酸などの有機酸、塩酸、硫酸、
リン酸などの鉱酸類が用いられ、通常(■)1モルに対
して065〜20モル、好ましくは1〜10モルが用い
られる。The above-mentioned reduction reaction and catalytic reduction reaction may be promoted in the presence of an acid catalyst. Examples of the acid catalyst include organic acids such as formic acid, acetic acid, propionic acid, trifluoroacetic acid, methanesulfonic acid, benzenesulfone M, p-toluenesulfonic acid, camphorsulfonic acid, hydrochloric acid, sulfuric acid,
Mineral acids such as phosphoric acid are used, and usually 0.65 to 20 mol, preferably 1 to 10 mol, per 1 mol (■).
[B
法]
アミノベンゾシクロアルカン(■〉のカルボニル化合物
(■)による還元アルキル化による(■)の製法は前記
A法またはこれに準じた方法により行うことができる。[Method B] The production of (■) by reductive alkylation of aminobenzocycloalkane (■) with a carbonyl compound (■) can be carried out by the above-mentioned Method A or a method analogous thereto.
[C法]
化合物(W)と酸クロリド(IX)との反応(アシル化
反応)は通常溶媒中で行われる。かかる溶媒としては反
応をさまたげないかぎりいかなる溶媒でもよく、たとえ
ば四次化炭素、クロロホルム、ジクロルメタン、1.1
. 2.2−テトラクロルエタンなどのハロゲン化炭化
水素類、酢酸エチル、酢酸メチルなどのエステル類、ア
セトン、メチルエチルケトンなどのケトン類、エチルエ
ーテル、イソプロピルエーテル、テトラヒドロフラン、
ジオキサンなどのエーテル類、ベンゼン、トルエン、キ
シレンなどの芳香族炭化水素類、ジメチルホルムアミド
、ジメチルスルホキシドが用いられる。[Method C] The reaction between compound (W) and acid chloride (IX) (acylation reaction) is usually carried out in a solvent. Any solvent may be used as such a solvent as long as it does not interfere with the reaction, such as quaternary carbon, chloroform, dichloromethane, 1.1
.. 2. Halogenated hydrocarbons such as 2-tetrachloroethane, esters such as ethyl acetate and methyl acetate, ketones such as acetone and methyl ethyl ketone, ethyl ether, isopropyl ether, tetrahydrofuran,
Ethers such as dioxane, aromatic hydrocarbons such as benzene, toluene, and xylene, dimethylformamide, and dimethyl sulfoxide are used.
また上記溶媒を混合物として用いてもよく、ショツテン
バウマン式の反応を行う場合は水あるいは、水と上記溶
媒の混合物を用いることもできる。Moreover, the above-mentioned solvents may be used as a mixture, and when carrying out a Schotten-Baumann reaction, water or a mixture of water and the above-mentioned solvents can also be used.
([)のかわりにカルボン酸の反応性誘導体(例、混合
酸無水物、活性エステルなど)を用いてもよい。本アシ
ル化反応は脱酸剤の存在下に行われてもよい。かかる脱
酸剤としては、たとえばトリメチルアミン、トリエチル
アミン、ピリジン、ピコリン、ジメチルアニリン、ジエ
チルアニリンなどの有機塩基類、水酸化ナトリウム、水
酸化カワラム、炭酸ナトリウム、炭酸カリウム、炭酸水
素ナトリウム、炭酸水素カリウムなどの無機塩基が用い
られ、通常(IX)1モルに対して1〜5モル、好まし
くは1〜2モルが用いられる。反応温度は通常−20’
〜100℃好ましくは=lO°〜50℃が用いられる。In place of ([), a reactive derivative of carboxylic acid (eg, mixed acid anhydride, active ester, etc.) may be used. This acylation reaction may be carried out in the presence of a deoxidizing agent. Examples of such deoxidizers include organic bases such as trimethylamine, triethylamine, pyridine, picoline, dimethylaniline, and diethylaniline, sodium hydroxide, kawaram hydroxide, sodium carbonate, potassium carbonate, sodium hydrogen carbonate, potassium hydrogen carbonate, and the like. An inorganic base is used, usually in an amount of 1 to 5 mol, preferably 1 to 2 mol, per 1 mol of (IX). The reaction temperature is usually -20'
~100°C, preferably =1O° ~50°C is used.
反応時間は通常15分〜24時間好ましくはは3o分〜
8時間である。得られたアシルアミノ体(X)を還元剤
と反応させ(X[)を製造する。かかる還元剤としては
A法で用いた還元剤が用いられるほか、たとえばルイス
酸(例、塩化アルミニウム、塩化亜鉛、三フッ化ホウ素
・エーテレートなど)と水素化リチウムアルミニウムの
混合物、有機酸(例、酢酸、トリフルオロ酢酸など)と
水素化ホウ素ナトリウムの混合物等を用いてもよい。溶
媒は反応をさまたげないかぎりいかなるものでもよく、
たとえばA法によって用いた溶媒を用いることができる
。反応温度は通常−10℃〜150℃、好ましくは一5
℃〜100℃が用いられる。反応時間は通常30分〜2
0時間好ましくは30分〜8時間である。得られる原料
化合物(II)、および(If)の1種である化合物(
■)及び(XI)は、上記公知の手段により単離した後
あるいは反応混合物のまま本発明の原料として供給され
る。Reaction time is usually 15 minutes to 24 hours, preferably 30 minutes to
It is 8 hours. The obtained acylamino compound (X) is reacted with a reducing agent to produce (X[). As such a reducing agent, in addition to the reducing agent used in Method A, for example, a mixture of a Lewis acid (e.g., aluminum chloride, zinc chloride, boron trifluoride etherate, etc.) and lithium aluminum hydride, an organic acid (e.g., A mixture of acetic acid, trifluoroacetic acid, etc.) and sodium borohydride may also be used. Any solvent may be used as long as it does not interfere with the reaction.
For example, the solvent used in Method A can be used. The reaction temperature is usually -10°C to 150°C, preferably -15°C.
°C to 100 °C is used. Reaction time is usually 30 minutes to 2
The time is preferably 30 minutes to 8 hours. The obtained raw material compound (II) and one type of compound (If) (
(2) and (XI) are supplied as raw materials for the present invention after being isolated by the above-mentioned known means or as a reaction mixture.
又、原料化合物(■)、(Vl)は、それぞれ公知の方
法、たとえば二定らの武田研究所報44巻。In addition, the raw material compounds (■) and (Vl) can be prepared by known methods, for example, Takeda Research Institute Bulletin Vol. 44 by Nisada et al.
171頁、1985年、同45巻、122頁。p. 171, 1985, vol. 45, p. 122.
1985年等に記載の方法あるいはそれに準した方法に
より合成することができる。化合物(■)。It can be synthesized by the method described in 1985 et al. or a method analogous thereto. Compound (■).
(■)、 ([)は、公知方法に準じて合成することが
できる。(■) and ([) can be synthesized according to known methods.
「作 用」
以下の薬理試験の結果は、本発明のベンゾシクロアルカ
ン誘導体(1)が優れた有用性を有することを示す。"Effect" The results of the following pharmacological tests show that the benzocycloalkane derivative (1) of the present invention has excellent utility.
1、アシル−CoA:コレステロールアシルトランスフ
ェラーゼ(A CA T >阻害作用。1. Acyl-CoA: cholesterol acyltransferase (A CAT >inhibitory effect).
[実験法]
酵素標本ACATはハイデル[He1der]らのジャ
ーナル オブ リピッド リサーチ[Journal
ofLipid Re5earch]、 24巻
、1127頁(1982年)に記載の方法に従って、2
0時間絶食させた6週齢雄性スプレイグードウリイ[S
prague −Dawley]ラットの小腸粘膜ミク
ロゾーム画分から調製した。[Experimental method] Enzyme specimen ACAT was published in the Journal of Lipid Research by Heider et al.
of Lipid Research], Vol. 24, p. 1127 (1982).
6-week-old male spray gourdfish [S
Prague-Dawley] was prepared from rat small intestinal mucosal microsomal fraction.
ACAT活性はへルゲルード[He1gerudコらの
方法(ジャーナル オブ リビッド リサーチ。ACAT activity was determined by the method of Helgerud et al. (Journal of Livid Research).
22巻、271頁、1981年)に従って、[1−”C
]オレオイル−CoAと内因性コレステロールカラのラ
ベル化コレステロールエステルの生成量を測定すること
によって算出した。22, p. 271, 1981), [1-”C
] Calculated by measuring the amount of labeled cholesterol ester produced from oleoyl-CoA and endogenous cholesterol.
[結 果]
表1には被験化合物10−’M添加したときのラベル化
コレステロールエステル生6阻害率(%)をACAT阻
害作用の指標として示す。[Results] Table 1 shows the inhibition rate (%) of labeled cholesterol ester bio6 when 10-'M of the test compound was added as an index of the ACAT inhibitory effect.
表1は、実施例で得られる化合物で代表される本願目的
物(1)が、優れたACAT阻害作用を有していること
を立証している。Table 1 proves that the objective product (1) of the present application, represented by the compounds obtained in the Examples, has an excellent ACAT inhibitory effect.
2、コレステロール負荷ラットにおける血漿コレステロ
ール低下作用
[実験法]
7週齢の雄性スプレィグートウリー[SpragueD
awley]ラットに1%コレステロール食(0,5%
コール酸及び5%オリーブ油を含む)を3日間与え、血
漿コレステロール値でグループ分けした後、0.01%
の被験化合物を含む同飼料でさらに4日間飼育した。飽
食状態で午前8:30〜10:00の間に採血し、血漿
コレステロール値を酵素的に測定した。化合物の摂取量
は摂餌量から計算して求めた。2. Plasma cholesterol-lowering effect in cholesterol-loaded rats [Experimental method] 7-week-old male Sprague D.
awley] Rats were given a 1% cholesterol diet (0.5%
(containing cholic acid and 5% olive oil) was given for 3 days, and after grouping by plasma cholesterol level, 0.01%
The mice were fed the same diet containing the test compound for an additional 4 days. Blood was collected between 8:30 a.m. and 10:00 a.m. in a satiated state, and plasma cholesterol levels were measured enzymatically. The amount of compound intake was calculated from the amount of food consumed.
[結 果]
表2に示すように、被験化合物はコレステロール負荷時
の血漿コレステロールを有意に低下した。[Results] As shown in Table 2, the test compound significantly lowered plasma cholesterol during cholesterol loading.
表−2は、実施例1の化合物で代表される本願目的物(
I)が、優れた血漿コレステロール低下作用を有してい
ることを立証している。Table 2 shows the object of the present invention (represented by the compound of Example 1).
I) has been proven to have an excellent plasma cholesterol lowering effect.
「実施例」
次に、参考例、実施例を挙げて、本発明をさらに詳しく
説明するが、本発明はこれらの実施例に限定されるべき
ものではない。"Examples" Next, the present invention will be explained in more detail with reference to reference examples and examples, but the present invention should not be limited to these examples.
参考例、実施例のカラムクロマトグラフィーにおける溶
出はT L C(Thin Lager Chroma
tography。The elution in column chromatography of Reference Examples and Examples was performed using TLC (Thin Lager Chromatography).
tography.
薄層クロマトグラフィー)による観察下に行われた。T
LC観察においては、TLCプレートとしてメルク(M
erck)社製のシリカゲル60 F ts−を、展開
溶媒としては、カラムクロマトグラフィーで溶出溶媒と
して用いられた溶媒を、検出法とじてUV検出器を採用
した。カラム用シリカゲルは同じくメルク社製のシリカ
ゲル60 (70〜230メツシ5)を用いた。This was done under observation using thin layer chromatography). T
For LC observation, Merck (M
Silica gel 60 Fts- manufactured by Erck) was used as the developing solvent, the solvent used as the elution solvent in column chromatography was used as the developing solvent, and a UV detector was used as the detection method. As the silica gel for the column, silica gel 60 (70-230 mesh 5) also manufactured by Merck was used.
尚、実施例、参考例で用いる略号は、次のような意義を
有する。The abbreviations used in Examples and Reference Examples have the following meanings.
ag:ミリグラム2gニゲラム、−: ミリリーター、
@p:融点。ag: milligram 2g nigerum, -: milliliter,
@p: Melting point.
また室温とあるのは約15〜25℃を意味する。Furthermore, room temperature means approximately 15 to 25°C.
実施例1
2−(2−クロロベンジルアミノ)インダン塩酸塩(0
,59g)のジクロロメタン(6,0−)懸濁液に、ト
リエチルアミン(0,28d)を加え10分間かき混ぜ
た後、2,4−ジフルオロフェニルイソシアネート(0
,26d)を滴加した。30分間かき混ぜ、水洗後無水
Mg5O,で乾燥した。溶媒を留去し、残留物にエーテ
ル−へ牛サンを加え結晶化させることによりN−(2−
クロロベンジル)−N’−(2,4−ジフルオロフェニ
ル)−N −(2−インダニル)ウレアを得た(0.7
8g、94.0%)。エタノールから再結晶し無色プリ
ズム晶を得た(0.59g、71.7%)。Example 1 2-(2-chlorobenzylamino)indane hydrochloride (0
, 59 g) in dichloromethane (6,0-), added triethylamine (0,28d) and stirred for 10 minutes.
, 26d) was added dropwise. The mixture was stirred for 30 minutes, washed with water, and dried over anhydrous Mg5O. The solvent was distilled off, and N-(2-
chlorobenzyl)-N'-(2,4-difluorophenyl)-N-(2-indanyl)urea was obtained (0.7
8g, 94.0%). Recrystallization from ethanol gave colorless prism crystals (0.59 g, 71.7%).
mp 119 120℃。mp 119 120℃.
元素分析値 C、、H、。C,QF、N、0として計算
値: C,66,91,H,4,64,N、 6.7
9実測値: C,66,83: H,4,66、N
、 6.73以下同様にして対応するアミノベンゾシク
ロアルカン誘導体とイソシアネートと反応させることに
よりつぎの実施例2〜51の化合物を得た。Elemental analysis values C,,H,. Calculated value as C, QF, N, 0: C, 66, 91, H, 4, 64, N, 6.7
9 Actual measurement value: C, 66, 83: H, 4, 66, N
, 6.73 The following compounds of Examples 2 to 51 were obtained by reacting the corresponding aminobenzocycloalkane derivative with an isocyanate in the same manner.
実施例2
N−ベンジル−N’−(2,4−ジフルオロフェニル)
−N −(2−インダニル)ウレア:mp 67−6
8℃(エタノール−へ牛サンから再結晶)。収率94.
0%。Example 2 N-benzyl-N'-(2,4-difluorophenyl)
-N-(2-indanyl)urea: mp 67-6
8°C (recrystallized from beef starch to ethanol). Yield: 94.
0%.
元素分析値 C*sHtoF tN toとして計算値
: C,73,00; H,5,33; N、
7.40実測値: C,72,87; H,s、a
o; N、 7.36実施例3
N−(2,4−ジフルオロフェニル)−N’−(2−イ
ンダニル)−N’−フェニルウレア:sp 122
123℃(エタノールから再結晶〉。。Elemental analysis value Calculated value as C*sHtoF tN to: C, 73,00; H, 5,33; N,
7.40 actual value: C, 72,87; H, s, a
o; N, 7.36 Example 3 N-(2,4-difluorophenyl)-N'-(2-indanyl)-N'-phenylurea: sp 122
123℃ (recrystallized from ethanol).
収率91.7%。Yield 91.7%.
元素分析値 C□H、、F 、N 、0として計算値:
C,72,52; H,4,98: N、 7
.69実測値: C,72,25; H,4,98
: N、 7.61実施例4
N−(2,4−ジフルオロフェニル)−N’−(2イン
ダニル)−N’−(2−フェニルエチル)ウレア:
mp 82−84℃(エタノール−エーテルから再結
晶)。収率76.5%。Elemental analysis value C□H,,F,N,calculated value as 0:
C, 72,52; H, 4,98: N, 7
.. 69 actual value: C, 72,25; H, 4,98
: N, 7.61 Example 4 N-(2,4-difluorophenyl)-N'-(2indanyl)-N'-(2-phenylethyl)urea: mp 82-84°C (regenerated from ethanol-ether) crystal). Yield 76.5%.
元素分析値 C,、H□F、N、0として計算値:
C,73,45; H,5,65; N、 7.1
4実測値: C,?3.09; H,5,60,N
、 6.80実施例5
N−(4−クロロベンジル)−N’−(2,4−ジフル
オロフェニル)−N −(2−インダニル)ウレア:
098−99℃(エタノールから再結晶)。収率88.
0%。Elemental analysis value C,,H□F,N,calculated value as 0:
C, 73,45; H, 5,65; N, 7.1
4 Actual measurement value: C,? 3.09; H, 5, 60, N
, 6.80 Example 5 N-(4-chlorobenzyl)-N'-(2,4-difluorophenyl)-N-(2-indanyl)urea: 098-99<0>C (recrystallized from ethanol). Yield: 88.
0%.
元素分析値 C、、H、、CNF 、N 、Oとして計
算値: C,66,91; H,4,64; N
、 6.79実測値: C,66,82; H,4
,63; N、 6.74実施例6
N−(2,4−ジフルオロフェニル)−N’−(2イン
ダニル)−N’−(1−フェニルエチル)ウレア:
mp 119 120℃(エタノールから再結晶)。Elemental analysis value C,, H,, CNF, N, Calculated value as O: C, 66,91; H, 4,64; N
, 6.79 Actual value: C, 66, 82; H, 4
,63; N, 6.74 Example 6 N-(2,4-difluorophenyl)-N'-(2indanyl)-N'-(1-phenylethyl)urea: mp 119 120°C (recrystallized from ethanol ).
収率9066%。Yield 9066%.
元素分析値 Ct−HttF −N toとして計算値
: C,73,45; H,5,65; N、
7.14実測値: C,73,47: H,5,6
7; N、 7.04実施例7
N−(2,4−ジフルオロフェニル)−N’−(2=イ
ンダニル)−N’−(1−フェニルプロピル)ウレア:
mp 118 119℃(−エタノールから再結晶)
。Elemental analysis value Calculated value as Ct-HttF-N to: C, 73,45; H, 5,65; N,
7.14 Actual measurement: C, 73, 47: H, 5, 6
7; N, 7.04 Example 7 N-(2,4-difluorophenyl)-N'-(2=indanyl)-N'-(1-phenylpropyl)urea: mp 118 119°C (-regenerated from ethanol crystal)
.
収率99.0%。Yield 99.0%.
元素分析値 C□H*aF、N 、Oとして計算値:
C,73,87,H,5,95; N、 6.89
実測値: C,?4.06; H,5,9g、
N、 6.82実施例8
N−(2,4−ジフルオロフェニル)−N′−(2−イ
ンダニル)−N’−(2−メチル−1−フェニルプロピ
ル)ウレア
trp 172 173°C(エタノールから再結晶
)。Elemental analysis value C□H*a Calculated value as F, N, O:
C, 73,87, H, 5,95; N, 6.89
Actual value: C,? 4.06; H, 5.9g,
N, 6.82 Example 8 N-(2,4-difluorophenyl)-N'-(2-indanyl)-N'-(2-methyl-1-phenylpropyl)urea trp 172 173 °C (from ethanol recrystallization).
収率96,4%。Yield 96.4%.
元素分析値 CtsHtgF tN toとして計算値
: C,?4.27: H,8,23; N、
6.66実測値: C,74,26,H,6,27;
N、 6.57実施例9
N−(2,4−ジフルオロフェニル)−N’−(2−イ
ンダニル)−N’−ジフェニルメチルウレアsp 1
41 142°C(エタノールから再結晶)。Elemental analysis value Calculated value as CtsHtgF tN to: C,? 4.27: H, 8, 23; N,
6.66 actual value: C, 74,26, H, 6,27;
N, 6.57 Example 9 N-(2,4-difluorophenyl)-N'-(2-indanyl)-N'-diphenylmethylurea sp 1
41 142°C (recrystallized from ethanol).
収率92.3%。Yield 92.3%.
元素分析値 Ct−Ht4F tN toとして計算値
: C,76,63; H,5,32; N、
6.16実測値: C,76,64; H,5,3
7,N、 6.01実施例1O
N−(2,4−ジフルオロフェニル)−N’−(2−イ
ンダニル)−N’−(2−メチルベンジル)ウレmp9
4−95℃(イソプロピルエーテルから再結晶)。収率
57,5%。Elemental analysis value Calculated value as Ct-Ht4F tN to: C, 76,63; H, 5,32; N,
6.16 Actual value: C, 76,64; H, 5,3
7,N, 6.01 Example 1O N-(2,4-difluorophenyl)-N'-(2-indanyl)-N'-(2-methylbenzyl)uremp9
4-95°C (recrystallized from isopropyl ether). Yield 57.5%.
元素分析値 C、、H、、F 、N 、Oとして計算値
・ C,73,45; H,5,65; N、 7
.14実測値: C,73,50,H,5,70,N
、 7.09実施例11
N−(2,4−ジフルオロフェニル)−N’−(2=イ
ンダニル)−N’−(3−メチルベンジル)ウレア
mp 72−73℃(イソプロピルエーテル−へ牛サ
ンから再結晶)。収率91.0%。Elemental analysis values: Calculated values as C,, H,, F, N, O: C, 73,45; H, 5,65; N, 7
.. 14 Actual measurement value: C, 73, 50, H, 5, 70, N
, 7.09 Example 11 N-(2,4-difluorophenyl)-N'-(2=indanyl)-N'-(3-methylbenzyl)urea mp 72-73°C (from beef san to isopropyl ether) recrystallization). Yield 91.0%.
元素分析値 C0H□F 、N 、0として計算値:
C,?3.45; H,5,65; N、 7.
14実測値: C,73,46,H,5,65,N、
7.10実施例12
N−(2,4−ジフルオロフェニル)−N’−(2−イ
ンダニル)−N’−(4−メチルベンジル)ウレア
履p91−92°C(イソプロピルエーテル結晶)。収
率76、9%。Elemental analysis value Calculated value as C0H□F, N, 0:
C,? 3.45; H, 5,65; N, 7.
14 actual measurements: C, 73, 46, H, 5, 65, N,
7.10 Example 12 N-(2,4-difluorophenyl)-N'-(2-indanyl)-N'-(4-methylbenzyl)urea p91-92°C (isopropyl ether crystal). Yield 76.9%.
元素分析値 C t4H −sF tN tOとして計
算値二 C, 73.45; H, 5.65;
N, 7.14実測値: C, ?3.68. H
, 5.62,N, 7.14実施例13
N−(4−イソプロピルベンジル)−N′−(24−ジ
フルオロフェニル)−N−(2−インダニル)ウレア
mp 119−120℃(イソプロピルエーテルから
再結晶)。収率97.6%。Elemental analysis value Calculated value as C t4H -sF tN tO C, 73.45; H, 5.65;
N, 7.14 Actual measurement value: C, ? 3.68. H
, 5.62, N, 7.14 Example 13 N-(4-isopropylbenzyl)-N'-(24-difluorophenyl)-N-(2-indanyl)urea mp 119-120°C (regenerated from isopropyl ether) crystal). Yield 97.6%.
元素分析値 C□H −sF tN toとして計算値
: C, 74.27; H, 6.23. N
, 6.66実測値: C, 74.21; H,
6.22. N, 6.59実施例14
N (4 tert−ブチルベンジル)−N’−(
2。Elemental analysis value Calculated value as C□H -sF tN to: C, 74.27; H, 6.23. N
, 6.66 Actual value: C, 74.21; H,
6.22. N, 6.59 Example 14 N (4 tert-butylbenzyl)-N'-(
2.
4−ジフルオロフェニル)− N − (2−インダニ
ル)ウレア
mp 114 115℃(エタノールから再結晶)
。4-difluorophenyl)-N-(2-indanyl)urea mp 114 115°C (recrystallized from ethanol)
.
収率94.3%。Yield 94.3%.
元素分析値 C 、、H 、llF 、N 、Oとして
計算値: C, 74.63; H, 6.49:
N, 6.45実測値: C, 74.96;
H, 6.54, N, 6.38実施例15
N−(2.4−ジフルオロフェニル)−N′−(2イン
ダニル)−N’−(2.4−ジメチルベンジル)ウレア
mp 101 102°C(イソプロピルエーテル
から再結晶)。収率80.2%。Elemental analysis values Calculated as C,,H,llF,N,O: C, 74.63; H, 6.49:
N, 6.45 Actual value: C, 74.96;
H, 6.54, N, 6.38 Example 15 N-(2,4-difluorophenyl)-N'-(2indanyl)-N'-(2,4-dimethylbenzyl)urea mp 101 102°C (Recrystallized from isopropyl ether). Yield 80.2%.
元素分析値 C t=H x−F tN toとして計
算値: C, 73.87. H. 5.95.
N, 6.89実測値: C, 74.82;
H, 5.94; N, 6、91実施例16
N−(2.4−ジフルオロフェニル)−N’−(2−イ
ンダニル)−N’−(2.5〜ジメチルベンジル)ウレ
ア
mp 127 128℃(イソプロピルエーテルか
ら再結晶)。収率91,5%。Elemental analysis value Calculated value as C t = H x - F tN to: C, 73.87. H. 5.95.
N, 6.89 Actual value: C, 74.82;
H, 5.94; N, 6, 91 Example 16 N-(2,4-difluorophenyl)-N'-(2-indanyl)-N'-(2.5-dimethylbenzyl)urea mp 127 128°C (Recrystallized from isopropyl ether). Yield 91.5%.
元素分析値 C□H□F 、N 、Oとして計算値:
C, ?3.87; H. 5.95; N,
6.1119実測値: C, 73.97: H,
6.00; N, 6.81実施例17
N−(2,4−ジフルオ07 エニル)−N ’ −(
2−インダニル)−N′−(2,4,6−トリメチルベ
ンジル)ウレア
mp 133−134℃(イソプロピルエーテルから
再結晶)。収率80.5%。Elemental analysis value Calculated value as C□H□F, N, O:
C.? 3.87;H. 5.95; N,
6.1119 Actual value: C, 73.97: H,
6.00; N, 6.81 Example 17 N-(2,4-difluoroenyl)-N'-(
2-indanyl)-N'-(2,4,6-trimethylbenzyl)urea mp 133-134°C (recrystallized from isopropyl ether). Yield 80.5%.
元素分析値 C=−H*−F −N−0として計算値:
C,74,27; H,6,23; N、 6
.66実測値: C,74,22; H,6,17
,N、 6.55実施例18
N−(2,4−ジフルオロフェニル)−N’−(2−イ
ンダニル)−N′−[1−(4−イソプロピルフェニル
)エチルコラレア
典P 145 146℃(エタノールから再結晶)。Elemental analysis value Calculated value as C=-H*-F -N-0:
C, 74, 27; H, 6, 23; N, 6
.. 66 actual value: C, 74,22; H, 6,17
, N, 6.55 Example 18 N-(2,4-difluorophenyl)-N'-(2-indanyl)-N'-[1-(4-isopropylphenyl)ethyl Coralea Dictionary P 145 146°C (from ethanol recrystallization).
収率93.1%。Yield 93.1%.
元素分析値 C−?HtsF −N toとして計算値
: C,74,63: H,6,49,N、 6.
45実測値: C,?4.71; H,e、sg;
N、 6.38実施例19
N−(2,4−ジフルオロフェニル)−N’−(2イン
ダニル)−N’−(2−メトキシベンジル)ウレア
mp 106−107℃(エタノールから再結晶)。Elemental analysis value C-? Calculated value as HtsF -N to: C, 74, 63: H, 6, 49, N, 6.
45 Actual measurement value: C,? 4.71; H, e, sg;
N, 6.38 Example 19 N-(2,4-difluorophenyl)-N'-(2indanyl)-N'-(2-methoxybenzyl)urea mp 106-107<0>C (recrystallized from ethanol).
収率95.1%。Yield 95.1%.
元素分析値 C−4HxtF tN to tとして計
算値: C,70,58; H,5,43; N
、 6.86実測値: C,70,88; H,5
,40; N、 6.91実施例2O
N−(2,4−ジフルオロフェニル)−N’−(2−イ
ンダニル)−N’−(2,4−ジメトキシベンジル)ウ
レア
mp 114−115℃(エタノールから再結晶)。Elemental analysis value Calculated value as C-4HxtF tN to t: C, 70,58; H, 5,43; N
, 6.86 Actual value: C, 70,88; H, 5
,40; recrystallized from ).
収率96.6%。Yield 96.6%.
元素分析値 C、、H□FtNtOsとして計算値:
C,68,48: H,5,52: N、 6.
39実測値: C,6B、34; H,5,55;
N、 6.31実施例21
N−(2,4−ジフルオロフェニル)−N’−(2−イ
ンダニル)−N’−(3,4−ジメトキシベンジル)ウ
レア
mp l 47−148℃(エタノールから再結晶)
。Elemental analysis value C,, Calculated value as H□FtNtOs:
C, 68, 48: H, 5, 52: N, 6.
39 actual measurements: C, 6B, 34; H, 5,55;
N, 6.31 Example 21 N-(2,4-difluorophenyl)-N'-(2-indanyl)-N'-(3,4-dimethoxybenzyl)urea mp l 47-148°C (recycled from ethanol) crystal)
.
収率92.4%。Yield 92.4%.
元素分析値 C□H,、F、N、O,として計算値:
C,68,48; H,5,52; N、 6.
39実測値: C,68,42,H,5,51,N、
6.36実施例22
N−(2,4−ジフルオロフェニル)−N’−(2−イ
ンダニル)−N’−(3,4,5−)リメトキシベンジ
ル)ウレア
lp 126−127℃(エタノールから再結晶)。Elemental analysis value Calculated value as C□H,, F, N, O,:
C, 68,48; H, 5,52; N, 6.
39 actual measurements: C, 68, 42, H, 5, 51, N,
6.36 Example 22 N-(2,4-difluorophenyl)-N'-(2-indanyl)-N'-(3,4,5-)rimethoxybenzyl)urea lp 126-127°C (from ethanol recrystallization).
収率78.7%。Yield 78.7%.
元素分析値 C*aHzs F −N to 4として
計算値: C,66,66; H,5,59;
N、 5.98実測値: C,66,63; H,
5,58:N、 5.91実施例23
N−(2,4−ジフルオロフェニル)−N’−(2−イ
ンダニル)−N’−(2−チエニルメチル)ウレア
會p6ロー67℃(インプロピルエーテルカラ結晶)。Elemental analysis value C*aHzs Calculated value as F -N to 4: C, 66,66; H, 5,59;
N, 5.98 Actual value: C, 66,63; H,
5,58:N, 5.91 Example 23 N-(2,4-difluorophenyl)-N'-(2-indanyl)-N'-(2-thienylmethyl)urea p6 low 67°C (inpropyl Ether color crystal).
収率97.4%。Yield 97.4%.
元素分析値 C,、H,、F,N,OSとして計算値:
C. 65.61: H, 4.72. N,
7.29実測値: C. 65.56; H,
4.71. N, 7.23実施例24
N−(2,4−ジフルオロフェニル)−N’−(2イン
ダニル)−N’−(2−ピリジルメチル)ウレア
ap105〜106℃(エタノールから再結晶)。Elemental analysis value C,,H,,F,N,calculated value as OS:
C. 65.61: H, 4.72. N,
7.29 Actual value: C. 65.56; H,
4.71. N, 7.23 Example 24 N-(2,4-difluorophenyl)-N'-(2indanyl)-N'-(2-pyridylmethyl)urea ap 105-106°C (recrystallized from ethanol).
収率96.5%。Yield 96.5%.
元素分析値 C□H 、、F 、N.Oとして計算値:
C, 69.65; H, s.os; N,
11.08実測値: C, 69.32; H,
5.0g. N. 10.95実施例25
N−(2.4−ジフルオロフェニル)−N’−(2イン
ダニル)−N’−(3−ピリジルメチル)ウレア
mp 130−131’C(エタノール−エーテルか
ら再結晶)。収率90.8%。Elemental analysis values C□H,,F,N. Calculated value as O:
C, 69.65; H, s. os;N,
11.08 Actual value: C, 69.32; H,
5.0g. N. 10.95 Example 25 N-(2,4-difluorophenyl)-N'-(2indanyl)-N'-(3-pyridylmethyl)urea mp 130-131'C (recrystallized from ethanol-ether). Yield 90.8%.
元素分析値 C□H+JtNsOとして計算値: C
, 69.65; H, 5.05; N, 11
.08実測値: C,69,47; H,5,17
; N、 10.79実施例26
N−7クロヘキシルメチルーN’−(2,4−ジフルオ
ロフェニル)−N −(2−インダニル)ウレア
sp 124−125℃(イソプロピルエーテルら再
結晶)。収率85.7%。Elemental analysis value Calculated value as C□H+JtNsO: C
, 69.65; H, 5.05; N, 11
.. 08 actual measurement value: C, 69,47; H, 5,17
N, 10.79 Example 26 N-7 Chlohexylmethyl-N'-(2,4-difluorophenyl)-N-(2-indanyl)urea sp 124-125°C (recrystallized from isopropyl ether). Yield 85.7%.
元素分析値 C tsH tsF −N toとして計
算値: C, 71.85; H, 6.82;
N, 7.29実測値: C, 72.15.
H, 6.86. N, 7.30実施例27
N−ベンジル−N’−(2.4−ジフルオロフェニル)
− N − (4 、 6−シメチルー2−インダニル
)ウレア
mp81−82℃(イソプロピルエーテルから再結晶)
。収率88.0%。Elemental analysis value Calculated value as C tsH tsF -N to: C, 71.85; H, 6.82;
N, 7.29 Actual value: C, 72.15.
H, 6.86. N, 7.30 Example 27 N-benzyl-N'-(2,4-difluorophenyl)
-N-(4,6-dimethyl-2-indanyl)urea mp81-82°C (recrystallized from isopropyl ether)
. Yield 88.0%.
元素分析値 C t=H =4F tN tOとして計
算値: C, 73.87; H, 5.95.
N, 6.89実測値: C, 74.02:
H, 5.99:N, 6.91実施例28
N−ヘンンルーN’−(2.4−ジフルオロフェニル)
−N−(4.7−シメトキシー2−インダニル)ウレア
mp 110−111°C(エタノールから再結晶)
。Elemental analysis value Calculated value as C t = H = 4F tN tO: C, 73.87; H, 5.95.
N, 6.89 Actual value: C, 74.02:
H, 5.99:N, 6.91 Example 28 N-hennru N'-(2,4-difluorophenyl)
-N-(4,7-Simethoxy2-indanyl)urea mp 110-111°C (recrystallized from ethanol)
.
収率87.4%。Yield 87.4%.
元素分析値 C.5H.、F,N,O.として計算値:
C, 68.48; H, 5.52; N,
6.38実測値: C, 6g.31. H,
5.37; N, 6.30実施例29
N−ベンジル−N′−(2.4−ジフルオロフェニル)
−N−(5.6−シメトキシー2−インタニル)ウレア
ip 116−117°C(エタノールから再結晶)
。Elemental analysis value C. 5H. , F.N.O. Calculated value as:
C, 68.48; H, 5.52; N,
6.38 Actual value: C, 6g. 31. H,
5.37; N, 6.30 Example 29 N-benzyl-N'-(2,4-difluorophenyl)
-N-(5,6-Simethoxy2-intanyl)urea ip 116-117°C (recrystallized from ethanol)
.
収率68,2%。Yield 68.2%.
元素分析値 C =sH x−F tN to sとし
て計算値: C, 6g.48; H, 5.52
; N, 6.39実測値: C, 6g.21.
H, 5.52. N, 6.43実施例3O
N−ベンジル−N′−(2.4−ジフルオロフェニル)
−N−(4.5.6− トリメトキシ−2−インダニル
)ウレア
収率74.4%(粉末状物質)。Elemental analysis value Calculated value as C = sH x - F tN to s: C, 6g. 48; H, 5.52
; N, 6.39 Actual value: C, 6g. 21.
H, 5.52. N, 6.43 Example 3O N-benzyl-N'-(2,4-difluorophenyl)
-N-(4.5.6-trimethoxy-2-indanyl)urea yield 74.4% (powdered material).
元素分析値 C 、、H 、、F 、N 、04として
計算値: C, 66、86; H, 5.59;
N, 5.98実測値: C, 66、71:H
, 5.61; N, 5.94実施例31
N−ベンジル=N’−(2.4−ジフルオロフェニル)
”−N−(4.7−シメトキシー5,6−シメチルー2
−インダニル)ウレア
mp 127−128℃(エタノールから再結晶)。Elemental analysis values C,, H,, F, N, calculated as 04: C, 66, 86; H, 5.59;
N, 5.98 Actual value: C, 66, 71:H
, 5.61; N, 5.94 Example 31 N-benzyl=N'-(2.4-difluorophenyl)
”-N-(4,7-simethoxy5,6-dimethyl-2
-indanyl) urea mp 127-128°C (recrystallized from ethanol).
収率89.6%。Yield 89.6%.
元素分析値 C t,H t@F tN=○,として計
算値: C, 69.51; H, 6.05;
N, 6.00実測値: C, 69.35;
H, 6.15; N, 5.89実施例32
N−(2,4−ジフルオロフェニル)−N’−(2−ヒ
ドロキシ−4−メトキシベンジル)−N′−(2−イン
ダニル)ウレア
mp 165−166℃(エタノールから再結晶)。Elemental analysis value C t,H t@F tN = ○, calculated value: C, 69.51; H, 6.05;
N, 6.00 Actual value: C, 69.35;
H, 6.15; N, 5.89 Example 32 N-(2,4-difluorophenyl)-N'-(2-hydroxy-4-methoxybenzyl)-N'-(2-indanyl)urea mp 165 -166°C (recrystallized from ethanol).
収率87.8%。Yield 87.8%.
元素分析値 C 、、H 、、F 、N 、0 3とし
て計算値: C, 67、92; H, 5.22
. N, 6.60実測値・ C, 67、70:H
, 5.20:N, 6.67実施例33
N−(2.4−ジフルオロフェニル)−N′−(4ヒド
ロキ7−3−メトキシベンジル)−N′−(2−インダ
ニル)ウレア
mp 130 131℃(イソプロピルエーテルか
ら再結晶)。収率76、5%。Elemental analysis value C,, H,, F, N, 0 Calculated value as 3: C, 67, 92; H, 5.22
.. N, 6.60 actual value/C, 67, 70:H
, 5.20:N, 6.67 Example 33 N-(2,4-difluorophenyl)-N'-(4hydroxy7-3-methoxybenzyl)-N'-(2-indanyl)urea mp 130 131 °C (recrystallized from isopropyl ether). Yield 76.5%.
元素分析値 C =4H −tF tN to sとし
て計算値: C, 67、92; H, 5.22
; N, 6.60実測値: C, 67、86.
H, 5.21. N, 6.59実施例34
N−(2.4−ジフルオロフェニル)−N′−(4ヒド
ロキシ−3,5−ジメトキシベンジル)−N’−(2−
インダニル)ウレア
mp 163−164℃(イソプロピルエーテルから
再結晶)。収率70.9%。Elemental analysis value Calculated value as C = 4H - tF tN to s: C, 67, 92; H, 5.22
; N, 6.60 Actual value: C, 67, 86.
H, 5.21. N, 6.59 Example 34 N-(2,4-difluorophenyl)-N'-(4hydroxy-3,5-dimethoxybenzyl)-N'-(2-
indanyl) urea mp 163-164°C (recrystallized from isopropyl ether). Yield 70.9%.
元素分析値 C t=H t4F xN tO 4とし
て計算値: C, 66、07; ”H, 5.32
; N,、 6.16実測値: C,65,83;
H,5,35,N、 5.96実施例35
N−(2,4−ジフルオロフェニル)−N’−(2イン
ダニル)−N’−(2,5−ジメトキシ−3゜4−ジメ
チルベンジル)ウレア
ap 116 117℃(エタ/−ルから再結晶)。Elemental analysis value Calculated value as C t = H t4F x N tO 4: C, 66, 07; ”H, 5.32
; N,, 6.16 Actual value: C, 65, 83;
H, 5,35, N, 5.96 Example 35 N-(2,4-difluorophenyl)-N'-(2indanyl)-N'-(2,5-dimethoxy-3°4-dimethylbenzyl) Urea ap 116 117°C (recrystallized from ethanol/ethanol).
収率98.7%。Yield 98.7%.
元素分析値 Ct7Ht@F −N !03として計算
値: C,69,51; H,6,05; N、
6.00実測値: C,69,34,H,6,06
,N、 5.97実施例36
N−(2,4−ジフルオロフェニル)−N’−(2イン
ダニル)−N’−(4−メトキシ−2,5−ジメチルベ
ンジル)ウレア
ap 140 141℃(エタノールから再結晶)。Elemental analysis value Ct7Ht@F -N! Calculated value as 03: C, 69,51; H, 6,05; N,
6.00 Actual value: C, 69,34, H, 6,06
, N, 5.97 Example 36 N-(2,4-difluorophenyl)-N'-(2indanyl)-N'-(4-methoxy-2,5-dimethylbenzyl)urea ap 140 141°C (ethanol recrystallized from ).
収率96.9%。Yield 96.9%.
元素分析値 CtmHxa F tN to tとして
計算値: C,71,54; H,6,00;
N、 6.42実測値: C,71,53: H,
6,05; N、 6.39実施例37
N−(2,4−ジフルオロフェニル)−N′−(4−ヒ
ドロキシ−2,5−ジメチルベンジル)−N’(2−イ
ンダニル)ウレア
mp 199−200℃(酢酸エチルから再結晶)。Elemental analysis value Calculated value as CtmHxa F tN to t: C, 71,54; H, 6,00;
N, 6.42 actual measurement value: C, 71,53: H,
6,05; N, 6.39 Example 37 N-(2,4-difluorophenyl)-N'-(4-hydroxy-2,5-dimethylbenzyl)-N'(2-indanyl)urea mp 199- 200°C (recrystallized from ethyl acetate).
収率52.1%。Yield 52.1%.
元素分析値 C□Ht−FtNtOtとして計算値:
C,71,08; H,5,73; N、 6.
63実測値: C,71,25; H,5,76、
N、 6.59実施例38
N−(2,4−ジフルオロフェニル)−N’−(4−ヒ
ドロキシ−3,5−ジメチルベンジル)−N ’−(2
−インダニル)ウレア
mp 170−171℃(酢酸エチル−へ牛サンから
再結晶)。収率29.1%。Elemental analysis value Calculated value as C□Ht-FtNtOt:
C, 71,08; H, 5,73; N, 6.
63 actual measurement value: C, 71,25; H, 5,76,
N, 6.59 Example 38 N-(2,4-difluorophenyl)-N'-(4-hydroxy-3,5-dimethylbenzyl)-N'-(2
-indanyl) urea mp 170-171°C (recrystallized from ethyl acetate). Yield 29.1%.
元素分析値 C□H,、F、N、O,として計算値:
C,71,08; H,5,73; N、 6.
63実測値: C,70,83: H,5,62;
N、 6.55実施例39
N−(2,4−ジフルオロフェニル)−N’−(4−ヒ
ドロキシ−2,3,5−)リメチルベンジル)−N’−
(2−インダニル)ウレア
mp l 84−185℃(エタ/−ルから再結晶)
。Elemental analysis value Calculated value as C□H,, F, N, O,:
C, 71,08; H, 5,73; N, 6.
63 actual measurement value: C, 70, 83: H, 5, 62;
N, 6.55 Example 39 N-(2,4-difluorophenyl)-N'-(4-hydroxy-2,3,5-)limethylbenzyl)-N'-
(2-indanyl)urea mp l 84-185℃ (recrystallized from ethanol)
.
収率80.3%。Yield 80.3%.
元素分析値 C、、H、、F 、N 、O,として計算
値: C,?1.54; H,6,00; N、
6.42実測値: C,?1.53; H,6,
05,N、 6.37実施例4O
N−(2,4−ジフルオロフェニル)−N’−(4−ヒ
ドロキシ−3,5−ジイソプロピルベンジル)−N’−
(2−インダニル)ウレア
mp 161−162℃(エタノールから再結晶〉。Elemental analysis value: C,, H,, F, N, O, Calculated value: C,? 1.54; H, 6,00; N,
6.42 Actual value: C,? 1.53; H, 6,
05,N, 6.37 Example 4O N-(2,4-difluorophenyl)-N'-(4-hydroxy-3,5-diisopropylbenzyl)-N'-
(2-indanyl)urea mp 161-162°C (recrystallized from ethanol).
収率75.5%。Yield 75.5%.
元素分析値 CteH!−2F tNto lとして計
算値: C,72,7+3; H,6,74;
N、 5.85実測値: C,62,61; H,
6,79; N、 5.80実施例41
N (5tert−ブチル−4−ヒドロキシ−2−メ
チルベンジル)−N’−(2,4−ジフルオロフェニル
)−N −(2−インダニル)ウレアtap 117
−119°C(エタノールから再結晶)。Elemental analysis value CteH! Calculated value as -2F tNto l: C, 72,7+3; H, 6,74;
N, 5.85 Actual value: C, 62,61; H,
6,79; N, 5.80 Example 41 N (5tert-butyl-4-hydroxy-2-methylbenzyl)-N'-(2,4-difluorophenyl)-N -(2-indanyl)urea tap 117
-119°C (recrystallized from ethanol).
収率82,3%。Yield 82.3%.
元素分析値 cts)Is。F、N、O,−1/2C*
HsOHとして
計算値: C,?1.44: H,6,82;
N、 5.75実測値: C,71,74,H,6,
84: N、 5.69実施例42
N−(3,5−ジーtert−ブチルー4−ヒドロキシ
ベンジル)−N’−(2,4−ジフルオロフェニル)−
N−(2−インダニル)ウレア
mp 125 126℃(へ牛サンから再結晶)。収
率70.0%。Elemental analysis value cts) Is. F, N, O, -1/2C*
Calculated value as HsOH: C,? 1.44: H, 6, 82;
N, 5.75 Actual value: C, 71, 74, H, 6,
84: N, 5.69 Example 42 N-(3,5-di-tert-butyl-4-hydroxybenzyl)-N'-(2,4-difluorophenyl)-
N-(2-indanyl)urea mp 125 126°C (recrystallized from Hegyu Sun). Yield 70.0%.
元素分析値 C□H、、F 、N 、0 、として計算
値: C,73,49; H,7,16; N、
5.53実測値: C,73,29; H,7,
17,N、 5.53実施例43
N−[1−(3,5−ジーtert−ブチに−4,−ヒ
ドロキシフェニル)エチル]−N’−(2,4−ジフル
オロフェニル)−N−(2−インダニル)ウレアsp
183−185℃(エタノールから再結晶)。Elemental analysis value C□H,,F,N,0,calculated value: C,73,49; H,7,16;N,
5.53 actual value: C, 73,29; H, 7,
17,N, 5.53 Example 43 N-[1-(3,5-di-tert-buty-4,-hydroxyphenyl)ethyl]-N'-(2,4-difluorophenyl)-N-( 2-indanyl) urea sp
183-185°C (recrystallized from ethanol).
収率67.6%。Yield 67.6%.
元素分析値 C1Ha s F t N to、として
計算値: C,73,82,H,7,36:N、 5
.38実測値: C,74,00; H,7,42
; N、 5.53実施例44
N−ベンジル−N’−(2,4−ジフルオロフェニル)
−N−(1,2,3,4−テトラヒドロ−2−ナフチル
)ウレア
mp 103−104℃(エタノール−ヘキサンから再
結晶)。収率91.6%。Elemental analysis value Calculated value as C1Ha s F t N to: C, 73, 82, H, 7, 36: N, 5
.. 38 actual measurement value: C, 74,00; H, 7,42
; N, 5.53 Example 44 N-benzyl-N'-(2,4-difluorophenyl)
-N-(1,2,3,4-tetrahydro-2-naphthyl)urea mp 103-104°C (recrystallized from ethanol-hexane). Yield 91.6%.
元素分析値 Ct4HtlF =N toとして計算値
: C,73,45; H,5,65,N、 7.
14実測値: C,73,26; H,5,57,
N、 7.18実施例45
N−(2,4−ジフルオロフェニル)−N’−(4−ヒ
ドロキシ−5−イソプロピル−2−メチルベンジル)−
N’−(2−インダニル)ウレア:ap 198−1
99℃(エタノールから再結晶)。Elemental analysis value Calculated value as Ct4HtlF =N to: C, 73,45; H, 5,65, N, 7.
14 actual measurement value: C, 73,26; H, 5,57,
N, 7.18 Example 45 N-(2,4-difluorophenyl)-N'-(4-hydroxy-5-isopropyl-2-methylbenzyl)-
N'-(2-indanyl)urea: ap 198-1
99°C (recrystallized from ethanol).
収率96.7%。Yield 96.7%.
元素分析値 C−?H1,F tN to−として計算
値: C,?1.98; H,6,26,N、 6
.22実測値: C,71,7g、 H,6,27
,N、 6.20実施例46
N−(2,4−ジフルオロフェニル)−N’−(4−ヒ
ドロキシ−2−イソプロピル−5−メチルベンジル’)
−N’−(2−インダニル)ウレア:mp 196−
197℃(エタノールから再結晶)。Elemental analysis value C-? Calculated value as H1,F tN to-: C,? 1.98; H, 6, 26, N, 6
.. 22 Actual measurement value: C, 71.7g, H, 6,27
, N, 6.20 Example 46 N-(2,4-difluorophenyl)-N'-(4-hydroxy-2-isopropyl-5-methylbenzyl')
-N'-(2-indanyl)urea: mp 196-
197°C (recrystallized from ethanol).
収率99.6%。Yield 99.6%.
元素分析値 C、、H、、F 、N 、O、として計算
値: C,71,98,H,6,26,N、 6.2
2実測値: C,72,04; H,6,21:N
、 6.28実施例47
N (5−tert−ブチル−4−ヒドロキシ−2メ
チル−3−プロピルベンジル)−N’−(2,4−ジフ
ルオロフェニル)−N−(2−17fニル)ウレア:
mp l 57−158℃(エタノールから再結晶)
。Elemental analysis value: Calculated as C,,H,,F,N,O,: C,71,98,H,6,26,N, 6.2
2 actual measurements: C, 72,04; H, 6,21:N
, 6.28 Example 47 N (5-tert-butyl-4-hydroxy-2methyl-3-propylbenzyl)-N'-(2,4-difluorophenyl)-N-(2-17fnyl)urea: mp l 57-158℃ (recrystallized from ethanol)
.
収率99,4%。Yield 99.4%.
元素分析値 C、、H、、F 、N 、O、として計算
値: C,73,49,H,7,16,N、 5.5
3実測値: C,73,63; H,7,10;
N、 5.53実施例48
N−(2,4−ジフルオロフェニル)−N’−(2イン
ダニル)−N′−(4−メチルチオベンジル)ウレア:
sp 102 103℃(エタノールから再結晶)。Elemental analysis values: C, , H, , F , N , O, calculated values: C, 73,49, H, 7,16, N, 5.5
3 actual measurements: C, 73,63; H, 7,10;
N, 5.53 Example 48 N-(2,4-difluorophenyl)-N'-(2indanyl)-N'-(4-methylthiobenzyl)urea: sp 102 103<0>C (recrystallized from ethanol).
収率92.0%。Yield 92.0%.
元素分析値 Ct4Ht−F −N−OSとして計算値
: C,67,90; H,5,22; N、
6.60実測値: C,68,15; H,5,1
9・ N、 6.63実施例49
N−ベンジル−N’−(2,4−ジフルオロフェニル)
−N−(6,7,8,9−テトラヒドロ−5H−6−ベ
ンゾシクロへブテニル)ウレア:mp 78−80℃
(イソプロピルエーテル−ヘキサンから再結晶)。収率
79.3%。Elemental analysis value Calculated value as Ct4Ht-F-N-OS: C, 67,90; H, 5,22; N,
6.60 actual value: C, 68,15; H, 5,1
9.N, 6.63 Example 49 N-benzyl-N'-(2,4-difluorophenyl)
-N-(6,7,8,9-tetrahydro-5H-6-benzocyclohebutenyl)urea: mp 78-80°C
(Recrystallized from isopropyl ether-hexane). Yield 79.3%.
元素分析値 C□H,4F、N、Oとして計算値:
C,73,87; H,5,95; N、 6.8
9実測値: C,74,06; H,5,95;
N、 6.92実施例5O
N−(5−tert−ブチル−4Lヒドロキシ−2メチ
ルヘンシル)−N′−(2,4−ジフルオロフェニル)
−N−(6,7,8,9−テトラヒドロ−5H−6−ヘ
ンジシクロへブテニル)ウレアmp 188−189
℃(アセトン−イソプロピルエーテルから再結晶)。収
率94.5%。Elemental analysis value Calculated value as C□H, 4F, N, O:
C, 73,87; H, 5,95; N, 6.8
9 Actual measurement value: C, 74,06; H, 5,95;
N, 6.92 Example 5O N-(5-tert-butyl-4Lhydroxy-2methylhensyl)-N'-(2,4-difluorophenyl)
-N-(6,7,8,9-tetrahydro-5H-6-hendicyclohebutenyl)urea mp 188-189
°C (recrystallized from acetone-isopropyl ether). Yield 94.5%.
元素分析値 C30H34F tN −Otとして計算
値: C,73,15; H,6,96; N、
5.69実測値: C,73,38; H,7,
13; N、 5.64実施例51
N−(3,5−ジーtert−ブチルー4−ヒドロ牛シ
ヘンシル)−N′−(2,4−ジフルオロフェニル)N
−(6,7,8,9−テトラヒドロ−5H−6ペンゾシ
クロへブテニル)ウレア:
mp 175 176℃(エタ/−ルから再結晶)。Elemental analysis value C30H34F Calculated value as tN -Ot: C, 73,15; H, 6,96; N,
5.69 Actual value: C, 73,38; H, 7,
13; N, 5.64 Example 51 N-(3,5-di-tert-butyl-4-hydrobutycinyl)-N'-(2,4-difluorophenyl)N
-(6,7,8,9-tetrahydro-5H-6penzocyclohebutenyl)urea: mp 175 176°C (recrystallized from ethanol).
収率91.6%。Yield 91.6%.
元素分析値 C、、H、oF 、N 、O、として計算
値: C,74,13; H,7,54; N、
5.24実測値: C,74,13; H,7,
61; N、 5.11実施例52
2−イソプロピル−6−メチルアニリン(0,22g)
、トリクロロメチルクロロホルメート(l0%トルエン
溶液;3.6d)及びトルエン(5−)の混合物を80
℃で4時間加熱した後、溶媒を留去することにより2−
イソプロピル−6−メチルフエニルイソジア不−トを調
製した。これをジクロロメタン(4,0wt1)に溶解
し、2−(3,5−ジtert−ブチルー4−ヒドロキ
シベンジルアミノ)インダン(0,35g)を加え、室
温で1時間かき混ぜた後、水洗後、無水Mg5O,で乾
燥した。溶媒を留去し残留物をヘキサンから結晶化させ
、N−(3,5−ジーtert−ブチルー4−ヒドロキ
シベンジル)−N −(2−インダニル)−N’−(2
−イソプロピル−6−メチルフェニル)ウレアを得た(
0゜42g、79.8%)。イソプロピルエーテルから
再結晶し無色針状晶を得た(0.25g、47.5%)
。Elemental analysis value C,, H, oF, N, O, calculated value: C, 74,13; H, 7,54; N,
5.24 Actual value: C, 74, 13; H, 7,
61; N, 5.11 Example 52 2-isopropyl-6-methylaniline (0.22 g)
, trichloromethyl chloroformate (10% toluene solution; 3.6d) and toluene (5-) at 80%
After heating at ℃ for 4 hours, 2-
Isopropyl-6-methylphenyl isodiabute was prepared. Dissolve this in dichloromethane (4,0wt1), add 2-(3,5-di-tert-butyl-4-hydroxybenzylamino)indane (0,35g), stir at room temperature for 1 hour, wash with water, and anhydride. It was dried with Mg5O. The solvent was distilled off and the residue was crystallized from hexane to give N-(3,5-di-tert-butyl-4-hydroxybenzyl)-N-(2-indanyl)-N'-(2
-isopropyl-6-methylphenyl)urea was obtained (
0°42g, 79.8%). Recrystallization from isopropyl ether gave colorless needles (0.25g, 47.5%)
.
lIp 149 150℃
元素分析値 C1H、、N 、○、として計算値:
C,79,81; H,8,80; N、 5.3
2実測値: C,79,68; H,8,78,N
、 5.18実施例53
2.4.6−トリメチル安息香酸(328mg)及びジ
フェニルホスホリルアジド(DPPA、660mg)の
ベンゼン(8、0り溶液にトリエチルアミン(0゜28
1R1)を滴加した。20分間室温でかき混ぜ、30分
間加熱還流することにより2,4.6−ドリメチルフエ
ニルイソシアネートを調製した。これを室温にもどして
2−(3,5−ジーtert−ブチルー4−ヒドロキシ
ベンジルアミノ)インダン塩酸塩(580mg)ついで
トリエチルアミン(0,21d)を加え室温で4時間か
き混ぜ、水、飽和NaHCo3水溶液、水で順次洗浄後
、無水M g S O+で乾燥した。溶媒を留去し残留
物をヘキサンで結晶化させることによりN−(3,5−
ジーtert−ブチルー4−ヒドロキシベンジル)−N
−(2−インダニル)−N’−(2,4,6−)ジメチ
ルフェニル)ウレアを得た(702+ig、 91.
3%)。イソプロピルエーテルから再結晶し無色針状晶
を得た(496mg。lIp 149 150℃ Elemental analysis value Calculated value as C1H,,N,○:
C, 79,81; H, 8,80; N, 5.3
2 Actual measurements: C, 79,68; H, 8,78, N
, 5.18 Example 53 2.4. A solution of 6-trimethylbenzoic acid (328 mg) and diphenylphosphoryl azide (DPPA, 660 mg) in benzene (8.0%) was added with triethylamine (0.28%).
1R1) was added dropwise. 2,4.6-Dolimethylphenyl isocyanate was prepared by stirring at room temperature for 20 minutes and heating under reflux for 30 minutes. This was returned to room temperature, 2-(3,5-di-tert-butyl-4-hydroxybenzylamino)indane hydrochloride (580 mg) and triethylamine (0,21d) were added, stirred at room temperature for 4 hours, water, saturated NaHCo3 aqueous solution, After washing successively with water, it was dried with anhydrous MgSO+. By distilling off the solvent and crystallizing the residue with hexane, N-(3,5-
tert-butyl-4-hydroxybenzyl)-N
-(2-indanyl)-N'-(2,4,6-)dimethylphenyl)urea was obtained (702+ig, 91.
3%). Recrystallization from isopropyl ether gave colorless needles (496 mg).
64.6%)。64.6%).
mp 104−106℃。mp 104-106℃.
元素分析値 C、、H、、N 、O、として計算値:
C,79,65,H,8,65,N、 5.46実測
値: C,79,36,H,8,73; N、 5
.31実施例54
実施例53と同様にして、N−(3,5−ジーtert
−ブチルー4−ヒドロ牛ジベンジル)−N−(2インタ
ニル)−N’−(2,4−ジメチルフェニル)ウレアを
製造した。Elemental analysis values: Calculated as C, H, N, O:
C, 79,65, H, 8,65, N, 5.46 Actual value: C, 79,36, H, 8,73; N, 5
.. 31 Example 54 In the same manner as in Example 53, N-(3,5-tert
-Butyl-4-hydrobovodibenzyl)-N-(2-intanyl)-N'-(2,4-dimethylphenyl)urea was produced.
sp 173−174℃(イソプロピルアルコールか
ら再結晶)。収率61.7%。sp 173-174°C (recrystallized from isopropyl alcohol). Yield 61.7%.
元素分析値 C ssH 4gN !O tとして計算
値: C, 79.48; H, 8.49;
N, 5.62実測値: C, 79.33; H
. 8.55. N, 5.47実施例55
実施例53と同様にして、N−(3,5−ジーtert
ーブチルー4ーヒドロ牛ジベンジル)−N−(2−イン
ダニル)−N’−(2.6−ジメチルフェニル)ウレア
を製造した。Elemental analysis value C ssH 4gN! Calculated value as O t: C, 79.48; H, 8.49;
N, 5.62 Actual value: C, 79.33; H
.. 8.55. N, 5.47 Example 55 In the same manner as in Example 53, N-(3,5-tert
-butyl-4-hydrobafdibenzyl)-N-(2-indanyl)-N'-(2,6-dimethylphenyl)urea was produced.
ap l 7 9 − 1 8 0℃(イソプロピル
アルコールから再結晶)。収率97.8%。ap l79-180°C (recrystallized from isopropyl alcohol). Yield 97.8%.
元素分析値 C s s H 4t Nt o tとし
て計算値: C, ?9.48; H, 8.49
; N, 5.62実測値: C, 79.48.
H. 8.54. N, 5、60実施例56
実施例1と同様にしてN−(2,4−ジフルオロフェニ
ル)−N’−(4−ヒドロキシ−3.5−ジメトキシベ
ンジル)−N’−(6,7,8.9−テトラヒドロ−5
H−6−ベンゾシクロへブテニル)ウレアを無色プリズ
ム晶として得た。収率84.4%。Calculated value as elemental analysis value C s s H 4t Nt o t: C, ? 9.48; H, 8.49
; N, 5.62 Actual value: C, 79.48.
H. 8.54. N, 5, 60 Example 56 N-(2,4-difluorophenyl)-N'-(4-hydroxy-3,5-dimethoxybenzyl)-N'-(6,7, 8.9-tetrahydro-5
H-6-benzocyclohebutenyl)urea was obtained as colorless prismatic crystals. Yield 84.4%.
mp187−188℃(エタノールから再結晶)。mp 187-188°C (recrystallized from ethanol).
元素分析値 CttHt−FtNxO4として計算値:
C, 67、21; H, 5.85: N,
5.81実測値: C, 66、93; H,
s.so; N. 5.74実施例57
実施例1と同様にしてN−(2.4−ジフルオロフェニ
ル)−N’−(6.7.8.9−テトラヒドロ−5H−
6−ベンゾシクロへブテニル)−N’−(4−トリフル
オロメチルベンジル)ウレアを無色粉末として得た。収
率75.5%。Elemental analysis value Calculated value as CttHt-FtNxO4:
C, 67, 21; H, 5.85: N,
5.81 Actual value: C, 66, 93; H,
s. so;N. 5.74 Example 57 N-(2,4-difluorophenyl)-N'-(6.7.8.9-tetrahydro-5H-
6-benzocyclohebutenyl)-N'-(4-trifluoromethylbenzyl)urea was obtained as a colorless powder. Yield 75.5%.
元素分析値 C ssH tsF sN toとして計
算値:C,65、82. H, 4,89; N,
5.90実測値:C,66゜05; H,4,93
; N、 5.83実施例58
実施例1と同様にしてN−(2,4−ジフルオロフェニ
ル)−N’−(6,7,8,9−テトラヒドロ−5H−
6−ベンゾシクロへブテニル)−N′−(2゜5−ジメ
チルベンジル)ウレアを無色粉末として得た。収率83
.4%。Elemental analysis value Calculated value as C ssH tsF sN to: C, 65, 82. H, 4,89; N,
5.90 Actual value: C, 66°05; H, 4,93
; N, 5.83 Example 58 N-(2,4-difluorophenyl)-N'-(6,7,8,9-tetrahydro-5H-
6-benzocyclohebutenyl)-N'-(2°5-dimethylbenzyl)urea was obtained as a colorless powder. Yield 83
.. 4%.
元素分析値 C=?HtJ tN !○として計算値:
C,74,63; H,6,49; N、 6
.45実測値: C,74,72; H,6,48
; N、 6.52実施例59
実施例1と同様にしてN−ベンジル−N’−(2゜4−
ジフルオロフェニル)−N−(1−インダニル)ウレア
を無色プリズム晶として得た。収率80゜5%、a+p
lo1 102℃(エタノール−へ牛サンから再結晶)
。Elemental analysis value C=? HtJtN! Calculated value as ○:
C, 74,63; H, 6,49; N, 6
.. 45 actual measurement value: C, 74,72; H, 6,48
; N, 6.52 Example 59 N-benzyl-N'-(2°4-
Difluorophenyl)-N-(1-indanyl)urea was obtained as colorless prism crystals. Yield 80°5%, a+p
lo1 102℃ (Recrystallized from beef sun to ethanol)
.
元素分析値 CzsHt。Ftr’JtOとして計算値
二 C,73,00; H,5,33; N、 7
.40実測値: C,72,78; H,5,35
,N、 7.:(4実施例60
実施例1と同様にしてN−ベンジル−N′−(2゜4−
ジフルオロフェニル)−N−(1,2,3,4テトラヒ
ドロ−1−ナフチル)ウレアを無色プリズム品として得
た。収率83.1%、mp149150°C(エタノー
ルから再結晶)。Elemental analysis value CzsHt. Calculated value as Ftr'JtO: C, 73,00; H, 5,33; N, 7
.. 40 Actual value: C, 72,78; H, 5,35
,N,7. :(4 Example 60 N-benzyl-N'-(2°4-
Difluorophenyl)-N-(1,2,3,4tetrahydro-1-naphthyl)urea was obtained as a colorless prism product. Yield 83.1%, mp 149150°C (recrystallized from ethanol).
元素分析値 C,、H□F 、N 、Oとして計算値:
C,73,45,H,5,65; N、 7.1
4実測値: C,73,44; H,5,79;
N、 7.19実施例6■
実施例1と同様にしてN−ベンジル−N’−(2゜4−
ジフルオロフェニル)−N−(6,7,8,9−テトラ
ヒドロ−58−5−ベンゾシクロへブテニル)ウレアを
無色針状晶として得た。収率64.2%、0Ip120
−121”C(エタノール−へ牛サンから再結晶)。Elemental analysis value Calculated value as C,, H□F, N, O:
C, 73,45, H, 5,65; N, 7.1
4 Actual measurements: C, 73,44; H, 5,79;
N, 7.19 Example 6■ In the same manner as in Example 1, N-benzyl-N'-(2゜4-
Difluorophenyl)-N-(6,7,8,9-tetrahydro-58-5-benzocyclohebutenyl)urea was obtained as colorless needles. Yield 64.2%, 0Ip120
-121''C (recrystallized from beef starch to ethanol).
元素分析値 C□Hffi、F 、N 、Oとして計算
値・ C,73,87; H,5,95; N、
6.89実測値: C,73,93; H,6、o
o; N、 6.80実施例62
実施例1と同様にしてN−(2,4−ジフルオロフェニ
ル)−N’−(4−ヒドロ牛シー3,5−ジメトキシベ
ンジル)−N’−(1−インタニル)ウレアを無色針状
晶として得た。収率70,3%、mp133−134°
C(エタノールから再結晶)。Elemental analysis value C□Hffi, calculated value as F, N, O・C, 73,87; H, 5,95; N,
6.89 Actual value: C, 73,93; H, 6, o
o; N, 6.80 Example 62 N-(2,4-difluorophenyl)-N'-(4-hydroboxy-3,5-dimethoxybenzyl)-N'-(1 -intanyl) urea was obtained as colorless needles. Yield 70.3%, mp133-134°
C (recrystallized from ethanol).
元素分析値 C,5H、、F 、N 、O、として計算
値: C,66,07: H,5,32; N、
6.16実測値: C,66,02; H,5,
32; N、 6.17実施例63
実施例1と同様にしてN−(2,4−ジフルオロフェニ
ル)−N’−(4−ヒドロキシ−3,5−ジメトキシベ
ンジル)−N’−(1,2,3,4−テトラヒドロ−1
−ナフチル)ウレアを無色プリズム晶として得た。収率
48.3%、+np96−98℃(エーテルから再結晶
)。Elemental analysis value: Calculated as C, 5H, F, N, O: C, 66,07: H, 5, 32; N,
6.16 Actual value: C, 66,02; H, 5,
32; N, 6.17 Example 63 N-(2,4-difluorophenyl)-N'-(4-hydroxy-3,5-dimethoxybenzyl)-N'-(1, 2,3,4-tetrahydro-1
-naphthyl)urea was obtained as colorless prismatic crystals. Yield 48.3%, +np 96-98°C (recrystallized from ether).
元素分析値 C、、H、、F 、N to、として計算
値: C,66,66、H,5,59,N、 5.9
8実測値・ C,66,43; H,5,69;
N、 5.88実施例64
実施例1と同様にしてN−(2,4−ジフルオロフェニ
ル)−N’−(6,7,8,9−テトラヒドロ5H−5
−ベンゾシクロへブテニル)−N ′−(4−ヒドロキ
シ−3,5−ジメトキシベンジル)ウレアを無色針状晶
として得た。収率61.5%、mp91−93°C(エ
タノール−ヘキサンから再結晶)。Elemental analysis value C,, H,, F, N to, calculated value: C, 66,66, H, 5,59, N, 5.9
8 Actual measurement value: C, 66,43; H, 5,69;
N, 5.88 Example 64 N-(2,4-difluorophenyl)-N'-(6,7,8,9-tetrahydro 5H-5
-benzocyclohebutenyl)-N'-(4-hydroxy-3,5-dimethoxybenzyl)urea was obtained as colorless needles. Yield 61.5%, mp 91-93°C (recrystallized from ethanol-hexane).
元素分析値 C,、H,、F、N、04として計算値:
C,67,21; H,5,85,N、 5.8
1実測値: C,67,14,H,5,79:N、
5.81実施例65
実施例1と同様にしてN−(4−クロマニル)−N’−
(2,4−ジフルオロフェニル)−N〜(4ヒドロキシ
−3,5−ジメトキシベンジル)ウレアを無色針状晶と
して得た。収率417%、mp122−123°C(エ
タノール−へ牛サンから再結晶)。Elemental analysis value C,,H,,F,N,calculated value as 04:
C, 67, 21; H, 5, 85, N, 5.8
1 actual measurement value: C, 67, 14, H, 5, 79:N,
5.81 Example 65 N-(4-chromanyl)-N'- in the same manner as in Example 1
(2,4-difluorophenyl)-N-(4hydroxy-3,5-dimethoxybenzyl)urea was obtained as colorless needles. Yield 417%, mp 122-123°C (recrystallized from beef starch to ethanol).
元素分析値 C、、H、、F 、N 、O、として計算
値: C,63,82; H,5,14; N、
5.95実測値: C,63,75; H,5,
11,N、 5.95実施例66
実施例1と同様にしてN−ベンジル−N−(7−クロロ
−4−クロマニル)−N’−(2,4−ジフルオロフェ
ニル)ウレアを無色プリズム品として得た。収率64,
7%、a+p148−149℃(エタノールから再結晶
)。Elemental analysis value Calculated as C,, H,, F, N, O,: C, 63,82; H, 5, 14; N,
5.95 actual value: C, 63,75; H, 5,
11,N, 5.95 Example 66 In the same manner as in Example 1, N-benzyl-N-(7-chloro-4-chromanyl)-N'-(2,4-difluorophenyl)urea was prepared as a colorless prism product. Obtained. Yield 64,
7%, a+p 148-149°C (recrystallized from ethanol).
元素分析値 Ct−H、CQF tN to tとして
計算値: c、 64.4f; )I、 4.47
; N、 6.53実測値: C,64,39;
H,4,49; N、 6.47実施例67
実施例1と同様にしてN−ベンジル−N’−(2゜4−
ジフルオロフェニル)−N−(1−チオクロマン−4−
イル)ウレアを無色針状晶として得た。Elemental analysis value Ct-H, CQF Calculated value as tN to t: c, 64.4f; )I, 4.47
; N, 6.53 Actual value: C, 64,39;
H, 4,49; N, 6.47 Example 67 N-benzyl-N'-(2°4-
difluorophenyl)-N-(1-thiochroman-4-
Il) urea was obtained as colorless needles.
収率80.0%、mp143−144℃(エタノールか
ら再結晶)。Yield 80.0%, mp 143-144°C (recrystallized from ethanol).
元素分析値 C!、H、、F 、N 、OSとして計算
値: C,67,30; H,4,91; N、
6.82実測値: C,67,43,H,4,96
; N、 6.74参考例1
2−インダノン(1,32g)、2−クロロベンジルア
ミン(1,42g)、酢酸(1,8成)及びメタノール
(20−)の混合物に、かき混ぜなからシアノ水素化ホ
ウ素ナトリウム(0,6g)のメタノール(3,0d)
溶液を滴加した。3時間室温でかき混ぜ、6N HcQ
(4,0IIt1)を加え、さらに30分間かき混ぜた
。6NNaOHでアルカリ性とし水を加え酢酸エチルで
抽出した。抽出液は水洗後、無水M g S O4で乾
燥した。溶媒を留去し残留物をエタノール(5,0d)
に溶解し、5N HCQ−エタノール溶液(4、0d)
を加えることにより、2−(2−クロロベンジルアミノ
)インダン塩酸塩を結晶として得た(2.0g、68.
0%)。エタノールから再結晶し無色板状晶を得た(1
.37g、46.6%)。Elemental analysis value C! ,H,,F,N,calculated as OS: C,67,30; H,4,91;N,
6.82 Actual value: C, 67,43, H, 4,96
N, 6.74 Reference Example 1 Add cyano to a mixture of 2-indanone (1,32 g), 2-chlorobenzylamine (1,42 g), acetic acid (1,8) and methanol (20-) without stirring. Sodium borohydride (0,6 g) in methanol (3,0 d)
The solution was added dropwise. Stir at room temperature for 3 hours, add 6N HcQ
(4,0IIt1) was added and stirred for an additional 30 minutes. The mixture was made alkaline with 6N NaOH, water was added, and the mixture was extracted with ethyl acetate. The extract was washed with water and then dried with anhydrous MgSO4. The solvent was distilled off and the residue was dissolved in ethanol (5.0d).
Dissolved in 5N HCQ-ethanol solution (4,0d)
By adding 2-(2-chlorobenzylamino)indane hydrochloride as crystals (2.0 g, 68.
0%). Recrystallization from ethanol gave colorless plate-like crystals (1
.. 37g, 46.6%).
mp 230 232℃。mp 230 232℃.
元素分析値 C,、H,、C2N−HCl2として計算
値: C,65,32; H,5,82; N、
4.76実測値: C,65,32,H,5,83
; N、 4.68以下同様にしてつぎの参考例2〜
28の化合物を製造した。Elemental analysis value C,, H,, calculated value as C2N-HCl2: C, 65,32; H, 5,82; N,
4.76 Actual value: C, 65, 32, H, 5, 83
; N, 4.68 Similarly, the following reference example 2~
28 compounds were prepared.
参考例2
2−ベンジルアミノインダン塩酸塩: mp230−2
35℃。Reference example 2 2-benzylaminoindan hydrochloride: mp230-2
35℃.
参考例3
2−フェニルアミノインダン ρ−トルエンスルホン酸
塩:mp224 225°C0参考例4
2−(2−フェニルエチルアミノ)インダン塩酸塩・a
+p255−256℃。Reference example 3 2-phenylaminoindan ρ-toluenesulfonate: mp224 225°C0 Reference example 4 2-(2-phenylethylamino)indan hydrochloride a
+p255-256°C.
参考例5
2−(4−クロロベンジルアミノ)インダン塩酸塩:
mp256 258℃。Reference Example 5 2-(4-chlorobenzylamino)indane hydrochloride:
mp256 258℃.
参考例6
2−(1−フェニルエチルアミノ)インタン塩酸塩 :
5p240 241’C0
参考例7
2−(1−7エニルブロピルアミノ)インダン塩酸塩:
mp218−220℃。Reference example 6 2-(1-phenylethylamino)intane hydrochloride:
5p240 241'C0 Reference Example 7 2-(1-7enylbropylamino)indane hydrochloride:
mp218-220℃.
参考例8
2−(2−メチル−1−フェニルプロピルアミノ)イン
ダン:5p73−74℃。Reference Example 8 2-(2-methyl-1-phenylpropylamino)indane: 5p73-74°C.
参考例9
2−ジフェニルメチルアミノインダン: mp7475
°C0
参考例10
2−(2−メチルベンジルアミノ)インダン塩酸塩:m
p250−252℃。Reference example 9 2-diphenylmethylaminoindan: mp7475
°C0 Reference example 10 2-(2-methylbenzylamino)indane hydrochloride: m
p250-252°C.
参考例11
2−(3−メチルベンジルアミノ)インタン塩酸塩:
mp259 260℃。Reference Example 11 2-(3-methylbenzylamino)intane hydrochloride:
mp259 260℃.
参考例12
2−(4−メチルベンジルアミノ)インダン塩酸塩:
mp250 251 ’C。Reference Example 12 2-(4-methylbenzylamino)indane hydrochloride:
mp250 251'C.
参考例13
2−(4−イソプロピルベンジルアミノ)インダン塩酸
塩二叶235−238℃。Reference Example 13 2-(4-isopropylbenzylamino)indane hydrochloride Niko 235-238°C.
参考例14
2 (4−tert−ブチルベンジルアミノ)インダ
ン塩酸塩二重p276−278℃。Reference Example 14 2 (4-tert-butylbenzylamino)indane hydrochloride double p276-278°C.
参考例l5
2−(2,4−ジメチルベンジルアミノ)インダン塩酸
塩:mp253 254℃。Reference Example 15 2-(2,4-dimethylbenzylamino)indane hydrochloride: mp253 254°C.
参考例16
2−(2,5−ジメチルベンジルアミノ)インダン塩酸
塩:a+p265−266℃。Reference Example 16 2-(2,5-dimethylbenzylamino)indane hydrochloride: a+p 265-266°C.
参考例17
2”[1−(4−イソプロピルフェニル)エチルアミノ
コインダン塩酸塩:ll1p263 265℃。Reference Example 17 2''[1-(4-isopropylphenyl)ethylaminocoindan hydrochloride: ll1p263 265°C.
参考例18
2−(2−メトキシベンジルアミノ)イ、ンダン塩酸塩
:g+p192 193℃。Reference Example 18 2-(2-methoxybenzylamino)i,ndane hydrochloride: g+p192 193°C.
参考例19
2−(2,4−ジメトキシベンジルアミノ)インダン塩
酸塩:ap215−216℃。Reference Example 19 2-(2,4-dimethoxybenzylamino)indane hydrochloride: ap 215-216°C.
参考例20
2−(3,4−ジメトキシベンジルアミノ)インダン塩
酸塩:ap231 232℃。Reference Example 20 2-(3,4-dimethoxybenzylamino)indane hydrochloride: ap231 232°C.
参考例21
2−(3,4,5−)ジメトキシベンジルアミノ)イン
ダン塩酸塩:鳳p235−236℃。Reference Example 21 2-(3,4,5-)dimethoxybenzylamino)indane hydrochloride: 235-236°C.
参考例22
2−(2−チエニルメチルアミノ)インダン塩酸塩、:
ap214 215°C0
参考例23
2−(2−ピリジルメチルアミノ)インダンジ塩酸塩:
mp202−205°C0
参考例24
2−(3−ピリジルメチルアミ/)インタンジ塩酸塩:
mp225−227℃。Reference Example 22 2-(2-thienylmethylamino)indane hydrochloride:
ap214 215°C0 Reference Example 23 2-(2-pyridylmethylamino)indane dihydrochloride:
mp202-205°C0 Reference Example 24 2-(3-pyridylmethylami/)intandihydrochloride:
mp225-227℃.
参考例25
2−シクロヘキシルメチルアミノインタン塩酸塩:mp
251−253°C0
参考例26
2−(3,5−ジーtert−ブチルー4−ヒドロキシ
ベンジルアミノ)インダン塩酸klA : mp228
231°C0
参考例27
2−[1−(3,5−ジーtert−ブチルー4−ヒド
ロキシフェニル)エチルアミノコインダン:油状物。Reference example 25 2-cyclohexylmethylaminointane hydrochloride: mp
251-253°C0 Reference Example 26 2-(3,5-di-tert-butyl-4-hydroxybenzylamino)indane hydrochloride klA: mp228
231°C0 Reference Example 27 2-[1-(3,5-di-tert-butyl-4-hydroxyphenyl)ethylaminocoindan: Oil.
参考例28
2−(2−ベンジルアミノ)−1,2,3,4−テトラ
ヒドロナフタレン塩酸塩:1p242−245C0
参考例29
2−アミノインダン(1,33g)、2,4.6−ドリ
メチルベンズアルデヒド(1,48g)、酢酸(1゜8
−)及びメタノール(15d)の混合物にシアノ水素化
ホウ素ナトリウム(0,6g)のメタ・メール(31n
Il)溶液を温和した。3時間室温でかき混ぜ、6NH
CQ(6,0りを加え、さらに30分間かき混ぜた。6
NNaOHを加えてアルカリ性とした抜水を加え酢酸エ
チルで抽出した。抽出液は水洗後無水Mg5O,で乾燥
した。溶媒を留去し残留物をエタノール(3−)に溶解
し5N HCC−エタノール溶液を加えることにより
2−(2,4,6−ドリメチルベンジルアミノ)インダ
ン塩酸塩を結晶トして得た(2.2g、73.1%)。Reference example 28 2-(2-benzylamino)-1,2,3,4-tetrahydronaphthalene hydrochloride: 1p242-245C0 Reference example 29 2-aminoindan (1,33 g), 2,4.6-drimethylbenzaldehyde (1.48g), acetic acid (1°8
-) and methanol (15d) in a mixture of sodium cyanoborohydride (0,6g) (31n
Il) The solution was warmed. Stir at room temperature for 3 hours, 6NH
Added 6.0 liters of CQ and stirred for an additional 30 minutes.6
Drained water was made alkaline by adding NNaOH and extracted with ethyl acetate. The extract was washed with water and then dried with anhydrous Mg5O. By distilling off the solvent, dissolving the residue in ethanol (3-), and adding 5N HCC-ethanol solution.
2-(2,4,6-drimethylbenzylamino)indane hydrochloride was crystallized (2.2 g, 73.1%).
エタノールから再結晶し無色板状晶を得た(2.01g
、66.8%)。Recrystallization from ethanol gave colorless plate crystals (2.01 g
, 66.8%).
ll1p2°82−283℃。ll1p2°82-283℃.
元素分析値 C4H!3N−HCQとして計算値:
C,75,60; H,8,01; N、 4.6
4実測値: C,75,64; H,g、14;
N、 4.63以下同様にして参考例30〜46の化
合物を製造した。Elemental analysis value C4H! Calculated value as 3N-HCQ:
C, 75,60; H, 8,01; N, 4.6
4 actual measurements: C, 75, 64; H, g, 14;
N, 4.63 Compounds of Reference Examples 30 to 46 were produced in the same manner.
参考例30
2−ベンジルアミ/−5,6−シメトキシインダン塩酸
塩:a+p273−275℃(分解)。Reference Example 30 2-Benzylamide/-5,6-simethoxyindane hydrochloride: a+p 273-275°C (decomposition).
参考例31
2−(4−ヒドロキシ−3,5−ジメトキシベンジルア
ミノ)インダン塩酸塩、199−200’C。Reference Example 31 2-(4-hydroxy-3,5-dimethoxybenzylamino)indane hydrochloride, 199-200'C.
参考例32
2−(4−ヒドロキン−3,5−ジメチルベンジルアミ
ノ)インダン:mp171−172°C(I水和物とし
て)。Reference Example 32 2-(4-Hydroquine-3,5-dimethylbenzylamino)indane: mp 171-172°C (as I hydrate).
参考例33
27−(2,5−ジメトキシ−3,4−ジメチルベンジ
ルアミノ)インダン塩酸塩: mp212213°C0
参考例34
2−(4−ヒドロキシ−2,5−ジメチルベンジルアミ
ノ)インダン塩酸塩:mp267−268°C0参考例
35
2−(4−メトキシ−2,5−ジメチルベンジルアミノ
)インダン塩酸塩:np253−254℃。Reference example 33 27-(2,5-dimethoxy-3,4-dimethylbenzylamino)indane hydrochloride: mp212213°C0 Reference example 34 2-(4-hydroxy-2,5-dimethylbenzylamino)indane hydrochloride: mp267 -268°C0 Reference Example 35 2-(4-methoxy-2,5-dimethylbenzylamino)indane hydrochloride: np253-254°C.
参考例36
2−(4−ヒドロ牛シー3.5−ジイソプロピルベンジ
ルアミノ)インダン塩M塩: mp 180−182℃
。Reference Example 36 2-(4-Hydroxy 3.5-diisopropylbenzylamino)indan salt M salt: mp 180-182°C
.
参考例37
2−(4−ヒドロキシ−2,3,5−トリメチルベンジ
ルアミノ)インダン:mp146−147℃。Reference Example 37 2-(4-hydroxy-2,3,5-trimethylbenzylamino)indane: mp146-147°C.
参考例38
2−(4−ヒドロ牛シー3−メト牛シベンジノ5アミノ
)インダン:mpH8−119℃。Reference Example 38 2-(4-Hydrocybenzino-5-amino)indane: mpH 8-119°C.
参考例39
2−(2−ヒドロキシ−4−メトキシベンジルアミノ)
インダン:5p105−106℃。Reference Example 39 2-(2-hydroxy-4-methoxybenzylamino)
Indane: 5p105-106°C.
参考例40
2 (5tert−ブチル−4−ヒドロキシ−2−メ
チルベンジルアミノ)インダン:mp169−170℃
。Reference example 40 2 (5tert-butyl-4-hydroxy-2-methylbenzylamino)indane: mp169-170°C
.
参考例41
2−(4−ヒドロキシ−5−インプロピル−2−メチル
ベンジルアミノ)インダン:s+p150−151’C
参考例42
2−(4−ヒドロキシ−2−イソプロピル−5−メチル
ベンジルアミノ)インダン塩酸塩:mp223−225
℃。Reference example 41 2-(4-hydroxy-5-inpropyl-2-methylbenzylamino) indane: s+p150-151'C Reference example 42 2-(4-hydroxy-2-isopropyl-5-methylbenzylamino) indane hydrochloride Salt: mp223-225
℃.
参考例43
2 (5−tert−ブチル−4−ヒドロキシ−2−
メチル−3−プロピルベンジルアミノ)インダン:sp
H0111’C0
参考例44
2−(4−メチルチオベンジルアミノ)インダン塩酸塩
: mp245 248℃。Reference Example 43 2 (5-tert-butyl-4-hydroxy-2-
Methyl-3-propylbenzylamino)indan: sp
H0111'C0 Reference Example 44 2-(4-methylthiobenzylamino)indane hydrochloride: mp245 248°C.
参考例45
6−ベンジルアミノ−6,7,8,9−テトラヒドロ−
5H−ベンゾシクロヘプテン塩酸塩:釣p220−22
1”C0
参考例46
2 (5−tert−ブチル−4−ヒドロキシ−2メ
チルベンジルアミノ)−6,7,8,9−テトラヒドロ
−58−ベンゾシクロヘプテン:5p152−153℃
。Reference example 45 6-benzylamino-6,7,8,9-tetrahydro-
5H-benzocycloheptene hydrochloride: Tsuri p220-22
1"C0 Reference Example 46 2 (5-tert-butyl-4-hydroxy-2methylbenzylamino)-6,7,8,9-tetrahydro-58-benzocycloheptene: 5p 152-153°C
.
参考例47
2−アミノ−4,6−シメチルインダン塩酸塩(1、0
g)、炭酸カリウム(0,84g)、酢酸エチル(10
成)及び水(10d)の混合物に、水冷下かき混ぜなが
ら、塩化ベンゾイル(0,621R1,)を滴加した。Reference Example 47 2-Amino-4,6-dimethylindane hydrochloride (1,0
g), potassium carbonate (0.84 g), ethyl acetate (10
Benzoyl chloride (0,621R1,) was added dropwise to a mixture of (1) and water (10d) while stirring under water cooling.
1時間水冷下にかき混ぜた後有機層を分取し、水洗後熱
水Mg5O,で乾燥した。溶媒を留去することにより
2−ベンゾイルアミノ−4,6−シメチルインダンを結
晶として得た(1.2g。After stirring for 1 hour under water cooling, the organic layer was separated, washed with water, and dried with hot water Mg5O. By distilling off the solvent
2-Benzoylamino-4,6-dimethylindane was obtained as crystals (1.2 g).
89.6%)。イソプロピルアルコールから再結晶し無
色針状晶を得た(1.1g、 82.1%)。89.6%). Recrystallization from isopropyl alcohol gave colorless needle crystals (1.1 g, 82.1%).
mpH9−120℃。mpH9-120°C.
上記結晶(1、0g)、水素化リチウムアルミニウム(
0,21g)及び乾燥テトラヒドロフラン(10kl)
の混合物を9時間加熱還流した。水冷下に水(1,0k
l)を滴加し析出物をろ去した。ろ液の溶媒を留去し残
留物に5N HCl2−エタノールを加えることにより
、2−ベンジルアミノ−4,6ジメチルインダン塩酸塩
を結晶として得た(0.4g、37.0%)。エタノー
ルから再結晶し無色針状晶を得た(0.3g、27.8
%)。mp267−268℃。The above crystal (1.0 g), lithium aluminum hydride (
0.21g) and dry tetrahydrofuran (10kl)
The mixture was heated under reflux for 9 hours. Water under water cooling (1,0k
1) was added dropwise and the precipitate was filtered off. The solvent of the filtrate was distilled off and 5N HCl2-ethanol was added to the residue to obtain 2-benzylamino-4,6 dimethylindane hydrochloride as crystals (0.4 g, 37.0%). Recrystallization from ethanol gave colorless needle crystals (0.3 g, 27.8
%). mp267-268℃.
元素分析値 C,、H,、N−HCl2として計算値:
C,75,11; H,7,70,N、 4.8
7実測値: C,?4.85; H,7,73,N
、 4.66以下同様にして参考例48〜50の化合物
を製造した。Elemental analysis value Calculated value as C,, H,, N-HCl2:
C, 75, 11; H, 7, 70, N, 4.8
7 Actual measurement value: C,? 4.85; H, 7, 73, N
, 4.66 Compounds of Reference Examples 48 to 50 were produced in the same manner as below.
参考例48
2−ベンゾイルアミノ−4,7−シメトキシインダン:
@p216 217℃。Reference example 48 2-benzoylamino-4,7-simethoxyindan:
@p216 217℃.
2−ベンジルアミノ−4,7−シメトキシインダン塩酸
塩:醜p237−239℃。2-Benzylamino-4,7-simethoxyindan hydrochloride: Ugly p237-239°C.
参考例49
2−ベンゾイルアミノ−4,5,6−ドリメトキシイン
ダン:ap125−126℃。Reference Example 49 2-Benzoylamino-4,5,6-drimethoxyindan: ap 125-126°C.
2−ベンジルアミノ−4,5,6−トリメトキシインダ
ン塩酸塩: mp206−207°C0参考例50
2−ベンゾイルアミノ−4,7−ジメトキシ5.6−シ
メチルインクン:mp173−174℃。2-Benzylamino-4,5,6-trimethoxyindan hydrochloride: mp206-207°C0 Reference Example 50 2-Benzoylamino-4,7-dimethoxy5,6-dimethylincan: mp173-174°C.
2−ベンジルアミノ−4,7−シメトキシー5゜6−シ
メチルインダン塩酸塩:mp230−231℃。2-Benzylamino-4,7-simethoxy 5°6-dimethylindane hydrochloride: mp230-231°C.
参考例51
4.7−シメトキシー1−インダノン(5、8g)の酢
酸エチル(60d)溶液に亜硝酸イソアミル(4,85
d)ついで 4N−HCl2−酢酸エチル(6−)を温
和した。室温で5時間かき混ぜることにより2−オキシ
イミノ−4,7−ジメトキシ−1インダノンを結晶とし
て得た(5.3g、79.9%)。メタノール−クロロ
ホルムから再結晶し黄色針状晶を得た。mp156−1
57°C0上記結晶(5g)、80%酢酸(100!R
1)、濃硫酸(5、0M>の混合物を5%パラジウム炭
素(2゜5g)の存在下に常圧、室温にて3日間水素添
加した。触媒をろ去し、溶媒を留去汲水で希釈した。Reference Example 51 Isoamyl nitrite (4,85
d) Then 4N-HCl2-ethyl acetate (6-) was added. By stirring at room temperature for 5 hours, 2-oximino-4,7-dimethoxy-1 indanone was obtained as crystals (5.3 g, 79.9%). Recrystallization from methanol-chloroform gave yellow needles. mp156-1
57°C0 The above crystals (5g), 80% acetic acid (100!R
1) A mixture of concentrated sulfuric acid (5.0 M) was hydrogenated in the presence of 5% palladium on carbon (2.5 g) at normal pressure and room temperature for 3 days. The catalyst was filtered off, and the solvent was distilled off. diluted with
炭酸カリウムで中和後、クロロホルムで抽出した。After neutralizing with potassium carbonate, the mixture was extracted with chloroform.
抽出液は無水Mg5O,で乾燥後溶媒を留去した。The extract was dried over anhydrous Mg5O and the solvent was distilled off.
残留物を酢酸エチル(30mffi)に溶解し5N H
(Jエタノールを加えることにより 2−アミノ−4,
7−シメトキシインタン塩酸塩を結晶として得た(3.
8g、73.2%)。エタノールから再結晶して無色針
状晶を得た。mp253−255℃。The residue was dissolved in ethyl acetate (30mffi) and diluted with 5N H
(By adding J ethanol 2-amino-4,
7-Simethoxyintane hydrochloride was obtained as crystals (3.
8g, 73.2%). Recrystallization from ethanol gave colorless needles. mp253-255℃.
元素分析値 C,、H,、NO,・HCQとして計算値
: C,57,52,H,7,02; N、 6.
10実測値: C,57t49. H,7,04;
N、 6.08以下同様にして参考例52〜54を
製造した。Elemental analysis value C,, H,, NO, Calculated value as HCQ: C, 57,52, H, 7,02; N, 6.
10 Actual value: C, 57t49. H,7,04;
N, 6.08 or less Reference Examples 52 to 54 were produced in the same manner.
参考例52
2−オキシイミノ−l−ペンゾスベロン:ap137
138℃。Reference example 52 2-oximino-l-penzosuberone: ap137
138℃.
6−アミノ−6,7,8,9−テトラヒドロ−5H−ベ
ンゾシクロヘプテン塩酸塩:
mp224−226℃。6-Amino-6,7,8,9-tetrahydro-5H-benzocycloheptene hydrochloride: mp224-226°C.
参考例53
2−オキシイミノ−4,6−シメチルー1−インダノン
: a+p237−239℃。Reference Example 53 2-oximino-4,6-dimethyl-1-indanone: a+p237-239°C.
2−アミノ−4,6−シメチルインダン塩酸塩:mp2
80−283°C(分解)。2-Amino-4,6-dimethylindane hydrochloride: mp2
80-283°C (decomposed).
参考例54
2−オキジイミノ−4,フーシメトキシー5,6−7メ
チルーl−インダノン:mp244 245C0
2−アミノ−4,7−シメトキシー5,6−シメチルイ
ンダン塩酸塩:mp292 296°C(分解)。Reference Example 54 2-Oxidiimino-4, fusimethoxy 5,6-7 methyl-1-indanone: mp244 245C0 2-Amino-4,7-simethoxy 5,6-dimethylindane hydrochloride: mp292 296°C (decomposition).
参考例29と同様の製法によりつぎの参考例55〜61
の化合物を製造した。The following Reference Examples 55 to 61 were produced by the same manufacturing method as Reference Example 29.
The compound was prepared.
参考例55
6.7,8.9−テトラヒドロ−6−(4−4リフルオ
ロメチルベンジルアミノ)−58−ベンゾシクロヘプテ
ン塩酸塩:mp241 243°C0参考例56
6−(4−ヒドロキシ−3,5−ジメトキシベンジルア
ミノ)−6,7,8,9−テトラヒドロ−5Hベンゾシ
クロヘプテン:+p140−141℃。Reference example 55 6.7,8.9-tetrahydro-6-(4-4lifluoromethylbenzylamino)-58-benzocycloheptene hydrochloride: mp241 243°C0 Reference example 56 6-(4-hydroxy-3 , 5-dimethoxybenzylamino)-6,7,8,9-tetrahydro-5H benzocycloheptene: +p140-141°C.
参考例57
6−(2,5−ジメチルベンジルアミノ)−6,7゜8
.9−テトラヒドロ−58−ベンゾシクロヘプテン塩酸
塩:mp238−240℃。Reference example 57 6-(2,5-dimethylbenzylamino)-6,7°8
.. 9-tetrahydro-58-benzocycloheptene hydrochloride: mp238-240°C.
参考例58
5−(4−ヒドロキシ−3,5−ジメトキシベンジルア
ミノ)−6,7,8,9−テトラヒドロ−5H−ベンゾ
シクロヘプテン p−トルエンスルホン酸塩:mp98
−103°C0
参考例59
1−(4−ヒドロキシ−3,5−ジメトキシベンジルア
ミノ)インダン シュウ酸塩:rnp204205℃。Reference Example 58 5-(4-hydroxy-3,5-dimethoxybenzylamino)-6,7,8,9-tetrahydro-5H-benzocycloheptene p-toluenesulfonate: mp98
-103°C0 Reference Example 59 1-(4-hydroxy-3,5-dimethoxybenzylamino)indan oxalate: rnp204205°C.
参考例60
1−(4−ヒドロキシ−3,5−ジメトキシベンジルア
ミノ>−1,2,3,4−テトラヒドロナフタレン P
−トルエンスルホン酸塩:np198200℃。Reference Example 60 1-(4-hydroxy-3,5-dimethoxybenzylamino>-1,2,3,4-tetrahydronaphthalene P
-Toluenesulfonate: np198200°C.
参考例61
4−(4−ヒドロキシ−3,5−ジメトキシベンジルア
ミノ)クロマン シュウM塩: a+p189190℃
。Reference Example 61 4-(4-hydroxy-3,5-dimethoxybenzylamino)chroman Shu M salt: a+p189190°C
.
参考例62
l−インダノン(2,64g)、ベンジルアミンぐ2゜
36g)、p−トルエンスルホン酸・水和物(0,6g
)。Reference Example 62 l-indanone (2.64g), benzylamine (2.36g), p-toluenesulfonic acid hydrate (0.6g)
).
ベンゼン(60Ml)の混合物をDean −5tar
kの水分分離器を付して7時間加熱還流した。冷後不溶
物をろ去しろ液の溶媒を留去。残留物をメタ/−ル(4
i)に溶解し水冷下にNaBH,(1,0g)を徐々に
加えた後、水冷下に1時間、室温で15時間かき混ぜた
。水を加え酢酸エチルで抽出した。A mixture of benzene (60Ml) was heated to Dean -5tar
A water separator was attached and the mixture was heated under reflux for 7 hours. After cooling, insoluble matter was removed by filtration and the solvent of the filtrate was distilled off. The residue was dissolved in methanol (4
After gradually adding NaBH (1.0 g) dissolved in i) under water cooling, the mixture was stirred for 1 hour under water cooling and for 15 hours at room temperature. Water was added and the mixture was extracted with ethyl acetate.
抽出液は水洗乾燥(MgS O、)後溶媒を留去。残留
物を5N HCl2−Ac0Etで処理することにより
1−ベンジルアミノインダン塩酸塩を結晶として得た。The extract was washed with water, dried (MgSO,), and the solvent was distilled off. The residue was treated with 5N HCl2-Ac0Et to obtain 1-benzylaminoindan hydrochloride as crystals.
エタノール−エーテルから再結晶し無色プリズム晶を得
た(2.48g、47.7%)。Recrystallization from ethanol-ether gave colorless prism crystals (2.48 g, 47.7%).
量p183−184℃
元素分析値 C、Hl?N ’ HC12として計算値
: C,?3.98; H,6,98,N、 5.
39実測値: C,74,02; H,7,04;
N、 5.04以下参考例62と同様の製法により
参考例63〜66の化合物を製造した。Quantity p183-184℃ Elemental analysis value C, Hl? N' Calculated value as HC12: C,? 3.98; H, 6,98, N, 5.
39 Actual value: C, 74,02; H, 7,04;
N, 5.04 or less Compounds of Reference Examples 63 to 66 were produced by the same manufacturing method as Reference Example 62.
参考例63
1−ベンジルアミノ−1,2,3,4−テトラヒドロナ
フタレン塩酸塩二mp175−179℃。Reference Example 63 1-benzylamino-1,2,3,4-tetrahydronaphthalene hydrochloride dimp 175-179°C.
参考例64
5−ベンジルアミノ−6,7,8,9−テトラヒドロ−
58−ベンゾシクロヘプテン塩酸塩:mp199−20
1℃。Reference example 64 5-benzylamino-6,7,8,9-tetrahydro-
58-benzocycloheptene hydrochloride: mp199-20
1℃.
参考例65
4−ベンジルアミノ−l−チオクロマン塩酸塩:■p1
43−144℃。Reference example 65 4-benzylamino-l-thiochroman hydrochloride: ■p1
43-144℃.
参考例66
4−ベンジルアミノ−7−クロロクロマン塩酸塩 二
會p193−196 ℃。Reference Example 66 4-benzylamino-7-chlorochroman hydrochloride 2
Meeting p193-196 ℃.
Claims (6)
素基を、Arは芳香環基を、Xは酸素原子またはイオウ
原子を、lは0または1を、mは3〜6を、nは0〜2
を示し、A環およびArはそれぞれ置換基を有していて
もよい。]で表わされるベンゾシクロアルカン誘導体ま
たはその塩。(1) General formula ▲ Numerical formula, chemical formula, table, etc. ▼ [In the formula, R is H or a hydrocarbon group that may have a substituent, Ar is an aromatic ring group, and X is an oxygen atom or a sulfur group. atom, l is 0 or 1, m is 3-6, n is 0-2
and each of ring A and Ar may have a substituent. ] A benzocycloalkane derivative or a salt thereof.
素基を、Arは芳香環基を、mは3〜6を、nは0〜2
を示し、A環およびArはそれぞれ置換基を有していて
もよい。]で表わされる請求項第(1)項記載のベンゾ
シクロアルカン誘導体またはその塩。(2) General formula ▲ Numerical formula, chemical formula, table, etc. ▼ [In the formula, R is H or a hydrocarbon group that may have a substituent, Ar is an aromatic ring group, and m is 3 to 6. , n is 0 to 2
and each of ring A and Ar may have a substituent. ] The benzocycloalkane derivative or salt thereof according to claim (1).
一般式 ▲数式、化学式、表等があります▼ で表わされるベンゾシクロアルカン誘導体またはその塩
の製造法[式中の記号は請求項第(1)項記載と同意義
を示す]。(3) A compound represented by the general formula ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ or a salt thereof, and a compound represented by the general formula Ar-(CH_2)_nNCO are reacted.
A method for producing a benzocycloalkane derivative or a salt thereof represented by the general formula ▲ Numerical formula, chemical formula, table, etc. ▼ [Symbols in the formula have the same meanings as described in claim (1)].
一般式 ▲数式、化学式、表等があります▼ で表わされるベンゾシクロアルカン誘導体の製造法[式
中の記号は請求項第(2)項記載と同意義を示す]であ
る請求項第(3)項記載のベンゾシクロアルカン誘導体
またはその塩の製造法。(4) A compound represented by the general formula ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ or a salt thereof, and a compound represented by the general formula Ar-(CH_2)_nNCO are reacted.
Claim No. (3) which is a method for producing a benzocycloalkane derivative represented by the general formula ▲ There are mathematical formulas, chemical formulas, tables, etc. A method for producing a benzocycloalkane derivative or a salt thereof as described in 2.
塩を含有してなるアシル−CoA:コレステロールアシ
ルトランスフェラーゼ阻害剤。(5) General formula ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ [Symbols in the formula indicate the same meaning as stated in claim item (1). ] An acyl-CoA:cholesterol acyltransferase inhibitor containing a benzocycloalkane derivative or a salt thereof.
塩を含有してなる請求項第(5)項記載のアシル−Co
A:コレステロールアシルトランスフェラーゼ阻害剤。(6) General formula ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ [Symbols in the formula indicate the same meaning as stated in claim item (2). ] The acyl-Co according to claim (5), which contains a benzocycloalkane derivative or a salt thereof.
A: Cholesterol acyltransferase inhibitor.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP13432189 | 1989-05-25 | ||
JP1-134321 | 1989-05-25 | ||
JP2-9264 | 1990-01-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH03261755A true JPH03261755A (en) | 1991-11-21 |
Family
ID=15125579
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP13633190A Pending JPH03261755A (en) | 1989-05-25 | 1990-05-24 | Benzocycloalkane derivative and production and drug thereof |
Country Status (2)
Country | Link |
---|---|
JP (1) | JPH03261755A (en) |
ZA (1) | ZA903906B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07503737A (en) * | 1992-05-28 | 1995-04-20 | フアイザー・インコーポレイテツド | Acyl-coenzyme A: Novel N-aryl and N-heteroaryl urea derivatives as inhibitors of cholesterol acyltransferase (ACAT) |
JP2003501417A (en) * | 1999-06-04 | 2003-01-14 | ノバルティス アクチエンゲゼルシャフト | Beta 2 adrenergic receptor agonist |
WO2011040509A1 (en) | 2009-09-30 | 2011-04-07 | 東レ株式会社 | 2,3-dihydro-1h-indene-2-ylurea derivative and pharmaceutical application of same |
-
1990
- 1990-05-21 ZA ZA903906A patent/ZA903906B/en unknown
- 1990-05-24 JP JP13633190A patent/JPH03261755A/en active Pending
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07503737A (en) * | 1992-05-28 | 1995-04-20 | フアイザー・インコーポレイテツド | Acyl-coenzyme A: Novel N-aryl and N-heteroaryl urea derivatives as inhibitors of cholesterol acyltransferase (ACAT) |
US8658673B2 (en) | 1999-04-06 | 2014-02-25 | Novartis Ag | BETA2-adrenoreceptor agonists |
US8796307B2 (en) | 1999-04-06 | 2014-08-05 | Novartis Ag | Beta2-adrenoreceptor agonists |
US9040559B2 (en) | 1999-04-06 | 2015-05-26 | Novartis Ag | BETA2-adrenoceptor agonists |
JP2003501417A (en) * | 1999-06-04 | 2003-01-14 | ノバルティス アクチエンゲゼルシャフト | Beta 2 adrenergic receptor agonist |
US8067437B2 (en) | 1999-06-04 | 2011-11-29 | Novartis Ag | Beta-2-adrenoreceptor agonists |
US8283362B2 (en) | 1999-06-04 | 2012-10-09 | Novartis Ag | Beta-2-adrenoreceptor agonists |
US8436017B2 (en) | 1999-06-04 | 2013-05-07 | Novartis Ag | Beta-2-adrenoreceptor agonists |
WO2011040509A1 (en) | 2009-09-30 | 2011-04-07 | 東レ株式会社 | 2,3-dihydro-1h-indene-2-ylurea derivative and pharmaceutical application of same |
AU2010301449B2 (en) * | 2009-09-30 | 2013-03-14 | Toray Industries, Inc. | 2,3-dihydro-1H-indene-2-ylurea derivative and pharmaceutical application of same |
US8653304B2 (en) | 2009-09-30 | 2014-02-18 | Toray Industries, Inc. | 2,3-dihydro-1H-indene-2-yl urea derivative and pharmaceutical application of same |
JP5573677B2 (en) * | 2009-09-30 | 2014-08-20 | 東レ株式会社 | 2,3-Dihydro-1H-inden-2-ylurea derivative and pharmaceutical use thereof |
Also Published As
Publication number | Publication date |
---|---|
ZA903906B (en) | 1992-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5480873A (en) | Pharmaceutical compounds | |
US5554642A (en) | Arylalkyl(thio) amides | |
EP0557171B1 (en) | Azaindoles, process for their preparation and medicines containing them | |
CA1064933A (en) | Benzoic acids, their derivatives and process for preparing them | |
AU632809B2 (en) | Benzocycloalkane benzopyran and benzothiopyran urea derivatives and production thereof | |
JPH0272136A (en) | Naphthalene derivative, production and synthetic intermediate thereof | |
Yee et al. | A novel series of selective leukotriene antagonists: exploration and optimization of the acidic region in 1, 6-disubstituted indoles and indazoles | |
CA2687948A1 (en) | Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein andhas glucocorticoid receptor-binding activity | |
EP0391799B1 (en) | Sulfonamides derived from benzocyclic or benzoheterocyclic acids, their preparation and their use in therapy | |
US6159988A (en) | Arylcycloalkyl derivatives, their production and their use | |
PL166392B1 (en) | Method of obtaining acetamide derivatives | |
US3890347A (en) | Isoindoline derivatives | |
CS110491A3 (en) | Hydroxamic acids and n-hydroxyureas as antiphlogistic compounds and process for preparing thereof | |
FR2930552A1 (en) | N-ACYLTHIOUREES AND N-ACYLUREES INHIBITORS OF THE HEDGEHOG PROTEIN SIGNALING PATHWAY | |
TW408099B (en) | Substituted kynurenines and process for their preparation | |
JPH04327564A (en) | New acylaminophenol compounds, method of manufacturing same and medicinal composition containing same | |
JPH0623123B2 (en) | Novel bicyclic compound, method for producing the same and pharmaceutical composition containing the same | |
US4515980A (en) | Substituted aminobenzoates, their preparation and use | |
JPH03261755A (en) | Benzocycloalkane derivative and production and drug thereof | |
JPH04243856A (en) | Substituted phenylacetylene, medicine containing same and process for producing said compund and said medicine | |
HUT56340A (en) | Process for producing tetrahydronaphthalene derivatives and pharmaceutical compositions comprising such compounds | |
EP0375560B1 (en) | Aryloxypropanolaminotetralines, process for their preparation and pharmaceutical compositions containing same | |
Musser et al. | N-[(arylmethoxy) phenyl] and N-[(arylmethoxy) naphthyl] sulfonamides: Potent orally active leukotriene D4 antagonists of novel structure | |
JPH01305078A (en) | Novel heteroarotinoide derivative | |
JPH02169571A (en) | Substituted allylamine derivative |